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Calorie  restriction  (CR)  may  extend  longevity  by  modulating  the  mechanisms  involved  in  aging.  Different
hypotheses have been proposed for its main mode of action. We quantified hepatic transcripts of male C57BL/6
mice exposed to graded levels of CR (0% to 40% CR) for three months, and evaluated the responses relative to
these various hypotheses. Of  the  four main  signaling pathways  implied  to be  linked  to  the  impact of CR on




which  was  paralleled  by  reduced  protection.  Downregulated  major  urinary  protein  (MUP)  transcription
suggested  reduced  reproductive  investment. Graded  CR  had  a  positive  effect  on  autophagy  and  xenobiotic
metabolism,  and was  protective with  respect  to  cancer  signaling.  CR  had  no  significant  effect  on  fibroblast
growth factor‐21 (FGF21) transcription but affected transcription in the hydrogen sulfide production pathway.
Responses  to CR were consistent with several different hypotheses, and  the benefits of CR on  lifespan  likely
reflect the combined impact on multiple aging related processes. 
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INTRODUCTION 
 
Aging is accompanied by many metabolic changes and 
elevated risks of metabolic, cardiovascular, neuro-
degenerative and other non-communicable diseases. 
Obesity, insulin resistance, inflammation and hyper-
tension are predisposing conditions that increase in 
prevalence during aging and contribute to the disease 
state known as the metabolic syndrome of aging [1]. In 
1935, evidence emerged that mammalian longevity 
could be increased by restricting food intake [2]. 
Nowadays, it is well established that restricting the 
amount of calories contributes to an increased lifespan 
and healthspan in many species [3–8], including non-
human primates [9]. CR also delays the onset of 
diseases related to the metabolic syndrome of aging, 
such as atherosclerosis, type 2 diabetes mellitus and 
cardiovascular diseases [10–12]. The mechanism(s) by 
which CR mediates its beneficial effects on aging are 
yet to be fully comprehended and are likely a result of 
changes simultaneously in many tissues and pathways. 
Mathematical models applied to mortality rates have 
been used to understand if CR postpones or slows the 
aging process [13]. Here, we analyzed the liver trans-
criptome as a part of a systems level description of 
graded CR responses [14–22]. From a clinical 
perspective the liver is well protected against aging 
relative to the other organs, but changes still occur in 
hepatic structure and function, such as declining liver 
regeneration, decreasing drug clearance and increasing 
bile cholesterol production [23]. Interestingly only four 
weeks of CR was able to reverse the majority of the 
aging-associated changes observed in murine liver [24]. 
Due to its central role in energy metabolism and glucose 
homeostasis, the liver is of great interest for genome-
wide analysis to understand whole-body aging. 
 
Different theories of aging have been proposed and over 
25 years ago it was estimated that there were already 
more than 300 aging theories [25]. Many of these old 
theories have laid the ground for the progress that has 
been made in the current aging research field. 
Explanations of the impact of CR on longevity have 
focused on a limited set of hypotheses derived from 
these different theories. These hypothetical impacts of 
different systems in the longevity effects of CR may 
converge on common pathways and are hence not 
mutually exclusive. 
 
Lifelong 40% CR alters hepatic fat metabolism by 
reducing lipogenesis, and increasing lipolysis and 
ketogenesis [26], while during aging there is a shift 
towards lipogenesis [27]. This alteration in lipid 
metabolism is believed to contribute to the CR-observed 
increase in lifespan [28,29]. During short-term CR, β-
oxidation is increased and triglyceride synthesis 
inhibited, which leads to an improvement of liver 
function [30]. The disposable soma theory of aging 
argues that organisms reallocate energy sources to 
maintain the soma, at the cost of investment in 
reproduction [31,32]. In addition, CR also induces a 
shift to β–oxidation of fatty acids, which produces 
flavin adenine dinucleotide (FADH). Unlike carbo-
hydrate utilization (nicotinamide adenine dinucleotide 
(NADH) production) FADH bypasses complex I in the 
electron transport chain, which is a primary site for 
reactive oxygen species (ROS) production [33]. The 
free radical theory of aging argues that accumulation of 
damage due to ROS leads to a gradual decline in 
cellular function [34]. CR could be protective against 
oxidative stress damage achieved by a decrease in the 
rate at which ROS are generated, an increase in the 
rate at which ROS are detoxified and/or an up-
regulation of degradation and repair processes 
(reviewed in [4]). 
 
Several major pathways have also been implicated to 
impart the beneficial effects associated with CR. These 
are reduced insulin/insulin like growth factor (IGF-1) 
signaling [15,35,36], reduced mechanistic target of 
rapamycin (mTOR) signaling [37], reduced nuclear 
factor-kappa beta (NF-κB) signaling [38] and increased 
sirtuin signaling [39]. Downregulation of the 
evolutionary conserved insulin/IGF-1 signaling pathway 
is associated with increase in lifespan in worms, flies 
and rodents [40–44]. The insulin/IGF-1 signaling 
pathway regulates its downstream effects via regulation 
of phosphoinositide-3-kinase (PI3K) and protein kinase 
B (AKT). In addition, the insulin/IGF-1 pathway has 
downstream effects on the mTOR complex 1 via 
AKT/Tuberous sclerosis 1 (TSC1). In response to 
nutrients and hormones, the mTOR signaling pathway 
can regulate protein synthesis, cellular growth and 
metabolism (reviewed in [45]). Inhibition of this 
pathway can increase lifespan in model organisms and 
inhibition is protective against aging-associated diseases 
(reviewed in [37]). NF-ĸB signaling is also associated 
with aging, mainly as its activation is linked with 
inflammation   and  known  lifespan  regulators  insulin/ 
IGF-1 and mTOR (reviewed in [38]). Increased sirtuin 
signaling has been found to increase lifespan in 
numerous species [46–49] and can also interact with the 
insulin signaling pathway [50]. Sirtuin signaling is 
linked to autophagy, and the increased autophagy under 
CR may contribute to the increase in lifespan [51,52]. 
Lastly the beneficial effects of CR on cancer are well 
known and its anti-cancer effect may also be involved 
in extending lifespan (reviewed in [53]). 
 
Many of these pathways have common signaling 
cascades and therefore might coincide in their effects. 
Hence, we concentrated on the main mechanisms 
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proposed for the anti-aging effects of CR: modulated 
insulin/IGF-1, mTOR, NF-ĸB and Sirtuin signaling, 
reduced oxidative stress, the disposable soma theory, 
anti-cancer mechanisms and increased autophagy. In 
addition, the role of fibroblast growth factor-21 
(FGF21), a hormone secreted by liver during fasting, 
has gained recent prominence in the aging field [54] and 
hydrogen sulfide (H2S) was also recently proposed to 
play a key role in aging [55]. We therefore included 
these in our analysis. Lastly, we also included 
xenobiotic metabolism as a separate mechanism from 
oxidative stress as suggested by studies in worms [56]. 
In most rats and mice increasing levels of CR in both 
sexes are linearly related to the increase in lifespan 
[3,4,57]. Hence the use of graded levels of CR as a 
research tool has gained much prominence in recent 
years [58–60]. C57BL/6 mice that are both known 
responders to CR and a well-studied strain, were the 
subject of the mouse genome project and are therefore 
ideal to study the graded effects of CR. Linear changes 
in gene expression with the level of restriction may 
likely be key components driving the longevity 
response. We therefore used a correlation approach 
across different levels of CR to investigate if the 
hypothesized mechanisms mediating the CR effect 
responded in a linear fashion when mice were exposed 




General correlation approach mapped onto 
pathways from IPA and custom built pathways 
 
We used 6 levels of restriction (5 month old male mice, 
restricted for 3 months until 8 months old): 24 hours ad 
libitum (AL) feeding, 12 hours AL feeding (time 
restricted feeding), 10% CR, 20% CR, 30% CR and 
40% CR which will be referred to as 24AL, 12AL, 
10CR, 20CR, 30CR and 40CR respectively. The gene 
expression levels were correlated with the increase in 
restriction. If a pathway mediated the effect of CR on 
lifespan, we expected gene expression in this pathway 
to correlate with the increase in CR level. We 
constructed several pathways that represent the different 
mechanisms related to aging. The pathways were 
custom built based on expert knowledge and curated 
databases using Ingenuity Pathway Analysis (IPA) 
software. The pathways were colored based on a cut-off 
of an absolute correlation coefficient higher than 0.3. 
Regulation of the downstream pathways from the aging 
mechanisms are identified by pathway analysis in IPA. 
In addition to the p-value for individual pathways we 
also calculated a z-value reflecting up or down 
regulation of the entire pathway (for more details see 
methods).  
The effect of graded CR on the insulin/IGF-1 
signaling pathway 
 
Insulin activates the insulin receptor (INSR) and 
downstream the insulin receptor substrate (IRS) family. 
Phosphorylated IRS proteins expose binding sites for 
signaling partners including PI3K which ultimately 
activates AKT. IGF-1 binds to its receptor (IGF1R) and 
induces a signaling cascade also via PI3K/AKT. In 
addition, AKT regulates mTOR via TSC1/TSC2. The 
INSR correlated positively with the increase in CR, 
probably reflecting the lowered levels of circulating 
insulin [15], while members of IRS family, PI3K, ATP 
citrate lyase (Acly) correlated negatively. Further 
downstream several target genes correlated negatively 
with the extent of CR (Figure1, Table S1). However, 
other components in this pathway correlated positively 
(Figure 1, Table S1). The PI3K/AKT (z-score: -3.138, 
p-value: 0.019) and IGF-1 signaling (z-score: -1.091, p-
value: 0.002) pathways were both significantly 
downregulated and hence the insulin/IGF-1 signaling 
appeared to be reduced in direct proportion to the 
increasing severity of CR. Significantly altered 
pathways downstream from Insulin/IGF-1 included 
changes in gluconeogenesis (z-score: 0.370, p-value: 
<0.001), lipolysis (z-score: NA, p-value: 0.046), and 
protein synthesis (z-score: -2.115, p-value: <0.001). 
 
We previously measured urinary major urinary proteins 
(MUPs), food anticipatory activity (FAA) and basal 
metabolic rate (BMR) in the same animals [15,18,21]. 
We assessed whether changes in urinary MUPs, FAA 
and BMR were associated with gene expression levels 
of genes involved in the insulin/IGF-1 signaling 
pathway. In total, gene expression levels of 13 genes 
involved in insulin/IGF-1 signaling correlated 
significantly with FAA, 7 with urinary MUPs and 10 
with BMR (Table 1). 
 
The effect of graded CR on the mTOR pathway 
 
mTOR exists in two complexes: mTORC1 and 
mTORC2. Complex one contains the regulatory 
associated protein of MTOR, complex 1 (RAPTOR or 
Rptor), MTOR associated protein, LST8 homolog (GBL 
or Mlst8) and AKT1 substrate 1 (PRAS40 or Akt1s1) 
while complex two contains GBL, RPTOR independent 
companion of MTOR, complex 2 (RICTOR), the 
PROTOR group and mitogen-activated protein kinase 
associated protein 1 (SIN1 or Mapkap1). Both mTOR 
complexes are stimulated by Ras homolog enriched in 
brain (RHEB) which is downstream from insulin, 
growth factor and nutrient signaling pathways. RHEB is 
negatively regulated by TSC1/2. Gene expression of the 
components of both mTORC1 and mTORC2 were 
negatively correlated with increasing CR level, 
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indicating significantly reduced signaling of mTOR 
under increasing CR (Figure 2, Table S2). Based on the 
correlation coefficient of the genes involved in 
mTORC1 and mTORC2, these 2 complexes were 
predicted in IPA to be negatively correlated with the 
increase in CR. However, no differences were observed 
between mTORC1 and mTORC2 in the extent of 
downregulation. The overall mTOR signaling pathway 
was indeed downregulated (z-score: -0.18, p-value: 
<0.001). Genes clustered together by IPA as the RHO 
group downstream from mTORC2 also correlated 
negatively with the increase in CR. RICTOR on the 
other hand correlated positively with the increase in CR. 
Expression levels of ribosomal protein S6 kinase beta-1 
(S6k1) did not correlate with the increase in CR. Graded 
CR significantly altered several pathways downstream 







































value: <0.001), lipid metabolism (z-score: NA, p-value: 
<0.001), angiogenesis (z-score: 0.829, p-value: <0.001), 
cell proliferation (z-score -0.357, p-value: <0.001) and 
protein synthesis (z-score: -2.115, p-value: <0.001). 
 
The effects of graded CR on NF-ĸB signaling 
 
The IKK complex (inhibitor of kappaB kinase beta 
(IKKβ) and conserved helix-loop-helix ubiquitous 
kinase (IKKα)) phosphorylates IκB proteins, and is 
activated by cytokines, growth factors and antigen 
receptors. Phosphorylation of IκB leads to downstream 
inactivation of the NF-κB/Rel complex via ubiquitina-
tion and proteasomal degradation. NF-κB/Rel proteins 
include NF-κB2 p52/p100, NF-κB1 p50, p65/v-rel 
reticuloendotheliosis viral oncogene homolog A (avian) 









































Figure  1.  The  insulin  like  growth  factor  (IGF‐1)/insulin pathway  created  in  the  Ingenuity  Pathway Analysis  (IPA,
www.qiagen.com/ingenuity)  program.  The  normalized  counts  for  each  gene were  correlated with  the  increase  in  calorie
restriction  (CR)  level  by  Pearson  correlation  method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation
coefficient higher than 0.3.. Red  indicates a positive correlation with  increasing CR  level while green indicates a negative correlation.
Circulating levels of insulin and IGF‐1 were significantly reduced in these CR mice [15] and this is indicated by a purple color.  
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oncogene related B (RelB) and transcribes target genes 
in the nucleus. In addition, IKKα can phosphorylate 
NF-κB2 p100 via an alternative pathway. This leads to 
downstream activation of RelB and induces target gene 
transcription in the nucleus. IĸB was positively 
correlated with the increase in CR level and the NF-
ĸB/RelB complexes were negatively correlated, 
indicating the increasing levels of CR progressively 
reduced signaling of this pathway (Figure 3, Table S3). 
NF-ĸB induced significant changes in the inflammation 
and immune response, cell proliferation (z-score -0.357, 
p-value: <0.001) and lymphogenesis (z-score: -0.539, p-
value: <0.001). 
 
We previously measured circulating hormone levels of 
the same mice [15] and assessed whether expression 
levels of genes involved in the NF-κB signaling path-
way were significantly associated with these hormones. 





































with interleukin 6 (IL6), 7 with tumor necrosis factor-
alpha (TNF-α) and 11 with IGF-1 (Table 2). 
 
The effects of graded CR on sirtuin signaling 
 
The sirtuin signaling pathway has shared signaling 
cascades with mTOR signaling, NF-ĸB and insulin 
signaling, and gene expression of some members of 
these pathways correlated negatively with the increase 
of CR (Figure 2-3, Table S2-S3). There are seven 
sirtuins in mammals (SIRT1-7) which are involved in 
various biological functions. We constructed this 
pathway based on the Sirtuins at a glance publication by 
Nakagawa and Guarente (2011) [61]. Of these 7 SIRTs 
only Sirt4 and Sirt7 correlated negatively with the 
increase in CR (Figure 4, Table S4). Target genes of 
Sirt4, insulin degrading enzyme (IDE) and solute carrier 
family 25 (mitochondrial carrier, adenine nucleotide 
translocator), member 5 (SLC254A), correlated 





































Table 1. Expression  levels of gene  involved  in  insulin/IGF‐1 signaling pathway 
correlated  with  urinary  major  urinary  proteins  (MUPs),  food  anticipatory 
activity (FAA) and basal metabolic rate (BMR). 
 MUPs FAA BMR 
 r p-value r p-value r p-value 
Acly 0.425 0.019 
Bad 0.419 0.042 -0.350 0.031 
Casp9 -0.488 0.016 
Eif4ebp1 -0.486 0.016 
Elk1 -0.428 0.037 0.407 0.011 
Foxo4 0.431 0.018 
Fyn -0.442 0.031 0.457 0.004 
Grb2 0.423 0.008 
Insr 0.408 0.048 -0.461 0.004 
Irs1 0.419 0.021 
Lipe -0.410 0.047 
Mapk8 0.495 0.014 -0.334 0.041 
Nck1 0.495 0.005 
Pde3b 0.530 0.008 -0.443 0.005 
Ptprf 0.440 0.015 -0.648 0.001 0.549 <0.001 
Rapgef1 -0.378 0.039 
Rhoq 0.490 0.015 -0.322 0.049 
Socs3 -0.441 0.031 
Srf -0.405 0.049 
Stx4a 0.680 <0.001 0.481 0.002 
Normalized  gene  counts  for  each  individual was  correlated with  their  corresponding 
physiological and behavioral data. 













































The effects of graded CR on oxidative stress 
signaling 
 
It has been hypothesized that CR may modulate 
oxidative stress by decreasing the rate at which ROS are 
generated, increasing the rate at which ROS are 
detoxified and upregulating degradation and repair 
processes (reviewed in [4]). This pathway includes 
processes such as nitric oxide (NO) production, nuclear 
factor erythroid derived 2 (NRF2) signaling, hypoxia-














































initiation factor 2 (eIF2) signaling, inducible nitric 
oxide synthase (iNOS) signaling and NF-ĸB signaling. 
Interleukins, TNF-α and insulin have been suggested to 
induce expression in this pathway. Under graded CR, 
gene expression in this pathway indicated that genes 
involved in the eIF2 signaling (z-score: 4.718, p-value: 
<0.001) were positively correlated with the extent of 
restriction while NRF2 (z-score: NA, p-value: 0.001) 
correlated negatively (Figure 5, Table S5). In addition, 
the production of ROS was predicted to be decreased 
(z-score: -0.305, p-value: <0.001).  
 









































We previously measured activity levels of antioxidants 
in livers of the same individual mice [15] and we 
assessed whether their expression levels correlated with 
the corresponding enzyme activity levels. The 
expression levels of the gene catalase (Cat) correlated 
positively with the measured actively levels of this 
antioxidant (r: 0.378, p-value: 0.019). Gene members of 
the superoxide dismutase family correlated negatively 
with activity levels of superoxide dismutase (Sod1 r: -
0.325 p-value: 0.046; Sod2 r: -0.335 p-value: 0.039). 
None of the gene members of the glutathione 
peroxidase (GPx) family correlated significantly with 
the anti-oxidant activity level of GPx. In total, 10 genes 
involved in oxidative stress correlated with SOD 
activity levels, 29 with catalase and 9 with GPx (Table 
3). Gene expression levels were also correlated with 
circulating hormone levels of the same mice [15] (Table 
4). In total 30 genes correlated significantly with leptin, 
33 with insulin, 23 with TNF-α, 10 with IL6, 34 with 





































The effects of graded CR on reproduction pathways 
 
Major urinary proteins (MUPs) are used by male mice 
in scent marking to attract females and their synthesis is 
a major cost of reproduction [31,62,63]. The p53 
signaling pathway has also been implicated to play are 
role in reproduction [64,65]. However downstream 
genes of p53 signaling did not correlate significantly 
with CR. Gene expression of the different MUPs all 
correlated negatively with the extent in restriction 
(Figure 6, Table S6). Expression levels of MUPs genes 
also correlated strongly in a positive manner with 
several circulating hormones measured in the same 
mice (Table 5). Other gene products involved in 
reproduction such as PPARGC1A, RAR-related orphan 
receptor gamma (RORC), phosphoenolpyruvate carbo-
xykinase 1, cytosolic (PCK1) and nuclear receptor 
subfamily 1, group I, member 2 (NR1I2) correlated 
strongly in a positive manner with the increase in CR 
(Table S6). 
 
Table  2.  Expression  levels  of  gene  involved  in  NF‐κB  signaling  pathway  correlated with 
levels of circulating hormones. 
leptin insulin IL6 TNF-α IGF-1 
 r p r p r p r p r p 
Azi2   -0.508 0.003   -0.376 0.031 -0.517 0.002 
Card11       0.391 0.024   
Cd4   0.417 0.016   0.429 0.013   
Chuk     -0.400 0.038     
Fadd       0.577 <0.001   
Gsk3b -0.371 0.034 -0.427 0.013     -0.568 0.001 
Malt1         -0.347 0.048 
Mapk8         -0.534 0.001 
Peli1   -0.361 0.039       
Prkcz         0.513 0.002 
Rela       0.360 0.039   
Ripk1 -0.416 0.016       -0.433 0.012 
Tab1         -0.367 0.036 
Tbk1         -0.368 0.035 
Tbp -0.374 0.032       -0.386 0.027 
Tdp2         -0.455 0.008 
Tirap 0.362 0.038 0.477 0.005       
Tradd       0.435 0.011   
Traf6         -0.492 0.004 
Ube2n       0.544 0.001   
Normalized gene counts for each individual was correlated with their corresponding physiological and 
behavioral data. 
















































The effects of graded CR on cancer signaling 
pathways 
 
A number of pathways are involved in cancer 
signaling, and show overlap with the oxidative stress 
signaling pathway (e.g. HIF1-α, NO, NRF2, iNOS). 
Expression of genes downstream from p53 did not 

















































negatively with the increase in CR. Hedgehog, TGF-β 
and Catenin beta 1 (CTNNβ) signaling all showed 
negative correlations to the extent of increasing CR 
(Figure 7, Table S7). The tumor suppressor genes of 
the SMAD family also correlated positively with CR 
(Figure 7, Table S7). The ‘disease function’ cancer 
was predicted to be strongly decreased (z-score: -
3.285, p-value: <0.001).  
 
Figure 3. The nuclear factor kappa B (NF‐ĸB) signaling pathway constructed in the Ingenuity Pathway Analysis (IPA,
www.qiagen.com/ingenuity)  program.  The  normalized  counts  for  each  gene were  correlated with  the  increase  in  calorie
restriction  (CR)  level  by  Pearson  correlation  method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation
coefficient higher than 0.3. Red indicates a positive correlation with increasing CR level while green indicates a negative correlation.
Circulating levels of insulin and TNF‐α were significantly reduced in these mice [15] and this is indicated by a purple color. 

















































































































Table  3.  Expression  levels  of  gene  involved  in  oxidative  stress  signaling 
correlated with activity levels of antioxidants. 
SOD catalase GPx 
r p-value r p-value r p-value 
Apex1 0.385 0.017 0.339 0.037 
Atf4 0.343 0.035 0.432 0.007 
Brca1 -0.329 0.044 
Calr 0.333 0.041 
Casp3 0.323 0.048 0.539 <0.001 
Cat 0.380 0.019 
Cbr1 -0.345 0.034 -0.382 0.018 
Crebbp -0.340 0.037 
Cul2 0.377 0.020 
Eif2a -0.423 0.008 
Eif2s1 0.324 0.047 
Eif4e 0.382 0.018 
Fkbp5 -0.457 0.004 
Fmo1 -0.472 0.003 
Fth1 -0.445 0.005 -0.387 0.016 
Hsp90aa1 0.415 0.010 
Hsp90b1 0.344 0.034 0.359 0.027 0.377 0.020 
Hspa5 0.388 0.016 
Insr -0.329 0.044 
Map2k1 0.371 0.022 0.379 0.019 
Map2k5 -0.321 0.049 
Mapk14 -0.370 0.022 -0.437 0.006 
Ncf4 0.392 0.015 
Nfkbia -0.419 0.009 
Ppib 0.334 0.040 
Prkcb 0.351 0.031 
Scarb1 -0.323 0.048 
Serpine1 
Shc1 0.410 0.011 
Stip1 0.438 0.006 
Taok3 -0.451 0.004 
Tdp1 0.412 0.010 
Trp53bp1 0.371 0.022 
Ube2e3 -0.427 0.008 
Usp14 0.340 0.037 
Vcp 0.448 0.005 0.330 0.043 
Normalized  gene  counts  for  each  individual was  correlated with  their  corresponding 
physiological and behavioral data. 


































The effects of graded CR on autophagy 
 
Starvation and nutrient deprivation induce autophagy. 
In addition, PI3K/AKT (insulin pathway) signaling 
activates mTOR and ERK/MAPK signaling negatively 
regulates mTOR, which both lead to an activation of 
mTOR and suppression of autophagy. Downstream 
from mTOR, UNC-51 like kinase 1 (ULK1) forms a 
large complex with autophagy related 13 (AGT13) and 
the scaffold protein FIP200. PI3K class III is required 
for the induction of autophagy. The ATG genes control 
autophagosome formation through ATG12/ATG5 
which requires ATG7 and ATG10. This induces the 
lipidated form of LC3 (LC3-II) which is attached to the 
autophagosome membrane. FIP200 and the further 
downstream AGT genes correlated positively with CR 
(Figure 8, Table S8). Similar results were found for 
LC3, LC3-I and LC3-II. Hence, autophagy was 
significantly increased with increasing levels of CR (z-
score: 0.833, p-value: <0.001). Gene expression levels 
of genes involved in autophagy correlated negatively 
with circulating levels of IGF-1 measured in the same 


































The effects of graded CR on mitochondrial 
biogenesis and fuel utilization 
 
We split mitochondrial biogenesis and fuel utilization 
into 5 separate pathways: Glycolysis, the tricarboxylic 
acid cycle (TCA) cycle, fatty acid β-oxidation, and the 
electron transport chain (ETC) combined with 
mitochondrial biogenesis genes and gluconeogenesis. 
The genes involved in glycolysis (z-score: NA, p-value: 
0.016), TCA cycle (z-score: NA, p-value: <0.001), fatty 
acid β-oxidation (z-score: 2.872, p-value: <0.001) and 
gluconeogenesis (z-score: 0.370, p-value: <0.001) all 
showed positive correlations with the extent of 
restriction (Figure 9A-D). Genes involved in the ETC 
were also positively correlated with the increase of CR, 
especially at complexes II, IV and V. Genes signaling 
mitochondrial dysfunction and apoptosis (z-score: -
1.504, p-value <0.001) were negatively correlated with 
CR (Figure 10, Table S9). In addition genes involved in 
ETC, gluconeogenesis, glycolysis and TCA correlated 
in general positively with FAA and negatively with 
circulating levels of leptin and insulin, body tempera-
ture and BMR measured in the mice (Figure 11). 
Figure 4. The sirtuin signaling pathway constructed in the Ingenuity Pathway Analysis (IPA, www.qiagen.com/ingenuity)
program. The normalized counts for each gene were correlated with the increase in calorie restriction (CR) level by Pearson correlation
method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation  coefficient  higher  than  0.3.  Red  indicates  a  positive
correlation with increasing CR level while green indicates a negative correlation.  

















































































































Table  4.  Expression  levels  of  gene  involved  in  oxidative  stress  signaling  correlated  with  levels  of 
circulating hormones. 
leptin insulin TNF-α IL6 IGF-1 resistin 
r p r p r p r p r p r p 
Abcc1 -0.422 0.028 
Abcc2 -0.471 0.006 -0.418 0.016 -0.563 0.001 
Abl1 -0.365 0.037 
Aox1 0.354 0.044 
Apex1 0.365 0.037 
Arnt -0.413 0.017 -0.556 0.001 
Atf2 -0.464 0.007 -0.544 0.001 
Bach1 -0.477 0.005 
Calr 0.374 0.032 0.621 
<0.00
1 0.517 0.002 0.545 0.001 
Casp9 0.429 0.026 
Cat 0.523 0.002 0.428 0.013 0.509 0.002 -0.497 0.008 0.625 
<0.00
1 
Cbr1 -0.570 0.001 -0.514 0.002 -0.383 0.028 -0.654 
<0.00
1 
Cbx5 -0.392 0.024 
Cdc25a -0.371 0.033 -0.373 0.033 -0.451 0.008 
Cdc34 -0.382 0.049 
Cdkn1a -0.403 0.037 
Clpp 0.554 0.003 -0.444 0.020 
Cops5 -0.410 0.034 
Crebbp -0.525 0.002 -0.419 0.015 -0.579 
<0.00
1 
Csf2ra -0.411 0.033 
Csf2rb2 -0.424 0.028 
Cul2 0.416 0.016 0.465 0.006 -0.453 0.018 
Cybb -0.437 0.023 
Eif1a -0.382 0.049 
Eif2a -0.396 0.023 -0.504 0.003 -0.433 0.012 
Eif2ak4 -0.478 0.005 
Eif2s1 -0.404 0.037 
Eif2s3x -0.553 0.001 
Eif4e -0.425 0.027 
Enc1 -0.404 0.020 -0.509 0.002 
Erp29 0.420 0.015 0.458 0.007 0.361 0.039 -0.495 0.009 
Fkbp5 -0.581 
<0.00
1 -0.487 0.004 -0.597 
<0.00
1 -0.515 0.002 
Fmo1 -0.605 
<0.00
1 -0.548 0.001 -0.647 
<0.00
1 -0.569 0.001 
Fth1 -0.415 0.016 0.427 0.027 -0.458 0.007 
Gclc 0.354 0.043 
Gsk3b -0.371 0.034 -0.427 0.013 -0.568 0.001 
Gsr -0.447 0.019 

















































































































H2afx -0.461 0.015 
Herpud1 -0.408 0.018 
Hif1a -0.401 0.038 
Hsp90aa
1 -0.501 0.008 
Hsp90b1 0.522 0.002 0.488 0.004 
Hspa5 -0.431 0.025 
Icam1 -0.397 0.040 
Insr -0.466 0.006 -0.546 0.001 -0.407 0.019 -0.481 0.005 
Maf -0.344 0.050 -0.478 0.005 -0.479 0.005 
Map2k1 0.427 0.013 0.354 0.043 0.373 0.032 -0.444 0.020 
Map3k1 -0.399 0.039 
Map3k5 -0.485 0.004 -0.644 
<0.00
1 -0.557 0.001 -0.394 0.023 
Mapk14 -0.560 0.001 -0.496 0.003 -0.380 0.029 -0.462 0.007 
Mapk8 -0.534 0.001 
Mdm2 -0.457 0.008 
Mdm4 -0.353 0.044 -0.578 
<0.00
1 
Ncf2 -0.417 0.030 
Ncf4 -0.460 0.016 
Ncoa1 -0.554 0.001 
Nfkbia -0.453 0.008 -0.507 0.003 -0.390 0.025 -0.478 0.005 
Pdpk1 -0.390 0.025 -0.525 0.002 
Plat -0.453 0.018 
Pmf1 0.388 0.046 
Ppara -0.392 0.024 0.508 0.007 
Ppib 0.427 0.013 0.650 
<0.00
1 0.492 0.004 0.530 0.002 
Ppp1r15
a -0.356 0.042 
Prdx1 0.360 0.039 
Scarb1 -0.383 0.028 0.400 0.039 
Serpine1 0.460 0.016 -0.452 0.018 
Shc1 -0.423 0.028 
Sirpa -0.433 0.024 
Sqstm1 -0.441 0.021 
Stip1 0.357 0.041 -0.411 0.033 
Taok3 -0.456 0.008 -0.507 0.003 -0.473 0.005 
Tlr4 -0.439 0.022 
Trim28 -0.415 0.016 
Trp53 -0.422 0.028 
Trp53bp
1 -0.520 0.005 
Txn1 0.406 0.019 0.403 0.020 -0.454 0.017 
Txnrd1 -0.458 0.016 

















































The effects of graded CR on FGF21 and the H2S 
pathway 
 
Gene expression levels of Fgf21 did not correlate with 
the extent of restriction (Table S10). H2S is generated in 
vivo by cystathionine-γ-lyase (CSE or Cth) and 
cystathionine-β-synthase (CBS) and was shown to have 

















































ratio and Sirt1 dependent manner [66]. Expression 
levels of genes involved in circadian rhythm such as 
period circadian clock 1 (Per1), Per2, cryptochrome 1 
(Cry1) and Cry2 were significantly positively correlated 
with CR. The circadian pathway itself however was not 
significantly altered with increasing CR levels (z-score: 
NA, p-value: 0.080). Cth correlated positively with CR 
while Cbs correlated negatively (Figure 12, Table S10).  
 




Ube2k -0.430 0.013 
Vcam1 -0.506 0.003 -0.422 0.015 -0.437 0.011 
Vcp 0.509 0.003 0.499 0.003 
Xbp1 0.438 0.011 0.370 0.034 0.485 0.004 
Normalized gene counts for each individual was correlated with their corresponding physiological and behavioral data. 

















































































































Table  5.  Gene  expression  levels  of major  urinary  proteins  (MUPs)  correlated with  circulating 
hormone levels. 
Insulin IGF-1 TNF-α Leptin 
r p-value r p-value r p-value r p-value 
Mup1 0.345 0.049 0.414 0.017 0.292 0.099 0.475 0.005 
Mup3 0.475 0.005 0.654 <0.001 0.443 0.010 0.732 <0.001 
Mup4 0.279 0.116 0.565 0.001 0.418 0.016 0.579 <0.001 
Mup5 0.319 0.070 0.595 <0.001 0.306 0.083 0.686 <0.001 
Mup6 0.338 0.055 0.521 0.002 0.343 0.051 0.645 <0.001 
Mup7 0.456 0.008 0.497 0.003 0.434 0.012 0.582 <0.001 
Mup8 0.486 0.004 0.431 0.012 0.452 0.008 0.618 <0.001 
Mup9 0.528 0.002 0.603 <0.001 0.450 0.009 0.592 <0.001 
Mup10 0.534 0.001 0.661 <0.001 0.464 0.006 0.739 <0.001 
Mup11 0.491 0.004 0.553 0.001 0.375 0.031 0.556 0.001 
Mup12 0.320 0.070 0.397 0.022 0.326 0.064 0.466 0.006 
Mup14 0.553 0.001 0.486 0.004 0.439 0.011 0.571 0.001 
Mup16 0.495 0.003 0.489 0.004 0.457 0.007 0.626 <0.001 
Mup17 0.440 0.010 0.516 0.002 0.382 0.028 0.636 <0.001 
Mup20 0.581 <0.001 0.640 <0.001 0.529 0.002 0.714 <0.001 
Mup21 0.447 0.009 0.558 0.001 0.368 0.035 0.669 <0.001 
Normalized  gene  counts  for  each  individual  was  correlated  with  their  corresponding  physiological  and 
behavioral data. 
Table 6. Expression  levels of genes  involved  in autophagy  correlated with  circulating hormone 
levels. 
Insulin IGF-1 TNF Leptin 
r p-value r p-value r p-value r p-value 
Atg10 -0.062 0.731 0.094 0.602 0.116 0.520 0.052 0.775 
Atg13 0.138 0.443 -0.166 0.356 0.185 0.303 -0.044 0.809 
Atg16l1 -0.297 0.093 -0.566 0.001 -0.148 0.412 -0.359 0.040 
Atg7 0.043 0.811 0.422 0.014 0.033 0.854 0.180 0.317 
Lamp2 0.298 0.092 0.656 <0.001 0.302 0.088 0.701 <0.001 
Map1lc3a -0.229 0.200 -0.133 0.460 -0.180 0.316 -0.131 0.469 
Map1lc3b -0.433 0.012 -0.166 0.355 -0.278 0.118 -0.426 0.013 
Rb1cc1 -0.502 0.003 -0.609 <0.001 -0.221 0.216 -0.296 0.095 
Stx17 -0.500 0.003 -0.456 0.008 -0.323 0.067 -0.335 0.057 
Wdfy3 -0.509 0.002 -0.466 0.006 -0.429 0.013 -0.446 0.009 
Normalized  gene  counts  for  each  individual  was  correlated  with  their  corresponding  physiological  and 
behavioral data. 
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The effects of graded CR on xenobiotic metabolism 
 
Constitutive active receptor (CAR, Nr1I3) is able to 
activate target genes by forming a complex with 
retinoid X receptor alpha (RXRα). Similar pregnane X 
receptor (PXR, Nr1I2) also forms a complex with 
RXRα. These activate transcription of enzymes 
involved in the xenobiotic metabolism. The xenobiotic 
metabolism consists of phase I, phase II and phase III 
enzymes. Phase I enzymes include the cytochrome P450 
family (CYP), flavin containing monooxygenase (FMO) 
and aldehyde dehydrogenase (ALDH). Transcription 
levels of Nr1I2, Nr1I3, Rxra, Fmo1, Fmo2, Fmo3, 
Fmo4, Cyp2c8, Cyp3a7, Aldh1a3, Aldh3a2, Aldh5a1, 









































associated with the increase in CR (Figure 13, Table 
S11). Overall metabolism of xenobiotics was predicted 





In this strain of mouse graded increases in CR leads to a 
graded increase in lifespan [67]: hence we suggested 
that changes at the molecular level mimicking this 
effect are likely to be more important than non-linear 
effects or responses that are constant across all levels. 
Here we found that graded CR had a graded impact on 
several different pathways in such a way that the 









































Figure 6. The  reproduction pathway  constructed  in  the  Ingenuity Pathway Analysis  (IPA, www.qiagen.com/ingenuity)
program. The normalized counts for each gene were correlated with the increase in calorie restriction (CR) level by Pearson correlation
method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation  coefficient  higher  than  0.3.  Red  indicates  a  positive
correlation with  increasing  CR  level while  green  indicates  a  negative  correlation.  Circulating  levels  of  insulin,  TNF‐α  and  leptin were
significantly reduced in these mice [15] and this is indicated by a purple color. 
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summarize, we found that insulin/IGF-1, NF-ĸB, and 
mTOR but probably not SIRT signaling pathways were 
correlated with graded CR in such a way that they may 
mediate the effect of CR on lifespan. The observed 
changes in fuel utilization related genes in relation to 
CR level may reduce oxidative stress. Reproductive 
investment in the form of MUPs were negatively 
associated with CR. Graded CR had a positive effect on 
autophagy and xenobiotic metabolism and CR was 
protective in cancer signaling. In addition, CR had no 













































positive significant effect on the H2S production 
mechanism. To aid the discussion of the results, we 
have included an integrated overview of the different 
pathways affected by graded CR (Figure 14).  
 
CR has transcriptional impacts on three of the four 
evolutionary conserved signaling pathways related 
to longevity 
 
The insulin/IGF-1 signaling pathway is evolutionary 













































Figure  7.  The  cancer  signaling  pathway  obtained  from  the  Ingenuity  Pathway  Analysis  (IPA,
www.qiagen.com/ingenuity) program. The normalized counts for each gene were correlated with the  increase  in calorie
restriction  (CR)  level by Pearson  correlation method.  The pathway  is  colored based on  a  cut‐off of  an  absolute  correlation
coefficient  higher  than  0.3.  Red  indicates  a  positive  correlation with  increasing  CR  level while  green  indicates  a  negative
correlation. The string of Xs represent DNA and indicate a transcriptional effect of a gene. 
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dies with Caenorhabditis elegans [40,68]. C. elegans 
mutants for the daf-2 gene (IGF-1 receptor), involved in 
insulin-like signaling, have a lifespan twice as long as 
wild types [41,50]. Mice lacking the insulin receptor 
substrate 1 (IRS1-/-) but not IRS2 (IRS2-/-) are long-
lived, but strangely have lifelong insulin resistance, 
while being also resistant against age-sensitive markers 
[43,44]. The mice studied here exhibited lower 
circulating levels of insulin and IGF-1 under CR [15]. 
This was correlated with improved glucose tolerance 
and improved insulin sensitivity [15]. In the present 
paper, we found that expression levels of hepatic genes 
involved in the insulin/IGF-1 signaling pathway 
generally correlated negatively with increasing CR, 
including members of the IRS family: hence the 
pathway was inhibited and increasingly so at higher 
levels of restriction. Insulin signaling activates glycogen 
synthesis for energy storage, suppresses hepatic glucose 
output and initiates lipogenesis. These processes are all 
reduced under CR [26] and we found significant 



































ed in the synthesis of fatty acids [69,70]. In agreement 
with other studies that have focused on single levels of 
restriction [15,35,36], these results indicate insulin/IGF-
1 signaling is reduced under CR in relation to the extent 
of restriction and hence may contribute to the graded 
increase in lifespan under graded CR [40–42]. 
However, elucidating the exact mechanism by which 
reduced insulin/IGF-1 regulates longevity is challenged 
by its complexity (reviewed in [71]). This pathway may 
mediate its beneficial effects via its impact on oxidative 
stress [72,73], the change in substrate utilization under 
CR [28,29], its impact in other pathways such as mTOR 
[74], xenobiotic detoxification mechanisms [75] and 
reproduction [76,77]. In addition, insulin and IGF-1 
have been implicated to play a role in cancer [78]. 
 
Similar to insulin, the role of mTOR in longevity was 
first established in C. elegans where mutations in 
mTOR and mTORC1 component raptor (daf-15) 
extended longevity [79,80]. In Drosophila melano-





































Figure  8.  The  autophagy  signaling  pathway  obtained  from  the  Ingenuity  Pathway  Analysis  (IPA,
www.qiagen.com/ingenuity)  program.  The  normalized  counts  for  each  gene were  correlated with  the  increase  in  calorie
restriction  (CR)  level  by  Pearson  correlation  method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation
coefficient higher than 0.3. Red indicates a positive correlation with increasing CR level while green indicates a negative correlation.
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of the mTORC1 also increased lifespan [81,82]. This 
was followed by studies in mice [83,84] indicating that 
mTOR is an evolutionary conserved regulator of 
longevity. Hence, reduced mTOR signaling as a result 
of CR may contribute to longevity and CR-induced 
health benefits (reviewed in [85]). mTORC1 regulates 
processes related to growth and differentiation while 
mTORC2 plays a regulatory role in the insulin cascade 
[86]. Disruption of mTORC1 leads to an increased 
lifespan [81,82] and is believed to be the primary 
complex to regulate longevity. In our graded CR study, 
expression levels of mTORC1 and mTORC2 were both 











































Deletion of S6K1, which is downstream from mTOR 
and insulin signaling, leads to an increased lifespan in 
female but not male mice [87]. S6K1 is a substrate of 
mTORC1 which is believed to be the main complex 
regulating longevity [88]. We found that graded CR had 
no effect on the expression levels of S6K1. However, 
activation of S6K1 is controlled via phosphorylation of 
at least 8 Ser/Thr residues [89]. mTOR can regulate 
S6K1 activation by either blocking an upstream S6K 
kinase or activating a phosphatase [89]. Although gene 
expression of S6K1 was not significantly altered in our 
data, its inhibition may be regulated via the down-












































Figure  9.  Fuel  utilization  pathways  obtained  from  the  Ingenuity  Pathway  Analysis  (IPA,  www.qiagen.com/ingenuity)
program. The normalized counts  for each gene were correlated with  the  increase  in calorie  restriction  (CR)  level by Pearson correlation
method. The pathway is colored based on a cut‐off of an absolute correlation coefficient higher than 0.3. Red indicates a positive correlation
with increasing CR level while green indicates a negative correlation. (A) glycolysis. (B) TCA cycle (C) fatty acid β‐oxidation. (D) gluconeogenesis. 
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downregulated mTORC1/2 may play a role in the effect 
of CR on longevity. However, the effects may be 
minimal in these male mice as suggested by the minor 
effect on lifespan of knocking out the S6K1 gene in 
male mice [87]. Given the strongly altered pathways 
downstream of mTOR (autophagy, protein synthesis 
etc) this suggests that mTOR may have CR responsive 
effects independent of S6K1 in male mice. Recent work 
suggested that downstream mTOR signaling in male 
mice may be regulated via eukaryotic translation 
initiation factor 4E binding protein 1 (4E-BP1) [90]. 
Transgenic 4E-BP1 male but not female mice are 
protected from ageing-induced obesity [90]. Our data 
suggests that processes downstream from mTOR may 
be activated in a S6K1 independent manner or that 
mTOR may not play a key role in extending lifespan in 
male mice under CR. 
 
A third pathway linked to aging is NF-ĸB signaling, 
mainly as its activation is linked to known lifespan 
regulators including insulin/IGF-1, mTOR and the 
sirtuins (reviewed in [38]). Inducible genetic inhibition 
of NF-ĸB in the epidermis of aged mice for two weeks 
































young mice [91]. NF-ĸB transcription factors are also 
evolutionary conserved and are mainly regulators of the 
immune system and inflammatory responses [92]. CR is 
known to reduce inflammation and decreased NF-ĸB 
signaling has been suggested to play a key role in this 
response [93]. TNF-α, a major pro-inflammatory 
cytokine, activates NF-ĸB and is also a transcriptional 
target of NF-ĸB [94]. The circulating levels of TNF-α 
were reduced in the mice studied here [15] and 
expression of NF-ĸB was negatively correlated with 
increasing CR level but examination of the direct 
correlation of NF-ĸB to TNF-α showed these 
correlations were not significant suggesting other 
factors were likely more important in the suppression of 
NF-ĸB reported here. In addition, RelA and its down-
stream genes were also downregulated. This would 
indeed suggest a reduced signaling of NF-ĸB under 
graded CR, resulting in less inflammation. In addition, 
NF-ĸB might also play a role in regulating energy 
metabolism that is independent of inflammation [95,96]. 
In cancer cells, RelA can regulate mito-chondrial 
function via binding to mitochondrial DNA and 
repressing gene expression affecting oxidative phospho-





































www.aging‐us.com  1789  AGING 
gene and an increase in p53 levels leads to an increase 
in oxidative phosphorylation and a decrease in 
glycolysis [95]. Gene expression levels of p53 were not 
altered in our study but we did observe an increase in 
expression of genes involved in glycolysis. The 
RelA/p63 complex can also increase glucose uptake via 
transcriptional regulation of the glucose transporter 
GLUT3 [96]. However, no changes were found in 

































Work with Saccharomyces cerevisiae, C. elegans and 
D. melanogaster indicated that lifespan can also be 
extended by overexpression of Sir2  [47–49] which may 
also interact with the insulin signaling pathway [50]. 
Mammals have 7 Sir2-like proteins (i.e. SIRT1-7) [98] 
and the loss of SIRT6 in SIRT6-deficient mice leads to 
abnormalities that were similar to ageing-associated 
degenerative processes [99]. Here we found little 
changes in expression levels of SIRTs and only Sirt4 
and Sirt7 were negatively correlated with the increase in 
CR level. SIRT4 knock out (KO) mice have a 30% 
increase in circulating levels of insulin during ad 
libitum feeding [100]. After an overnight fast, the KO 
mice had higher insulin levels compared to their wild 
type littermates which was not due to due to glucose 
intolerance. In fact the fasted KO mice had a slightly 
improved glucose tolerance [100]. During CR, SIRT4 
activity was downregulated and Haigis et al (2006) 
postulates this is due to the switch towards amino acid-
stimulated insulin secretion they identified in the KO 
mice. This is in agreement with our results were we also 
found a decrease in expression levels of SIRT4 with 
increasing CR. Here, we found that fatty acid β-
oxidation is upregulated during CR, which is in 
agreement with others [101]. This would lead to a 
reduction in NAD/NADH ratio in the liver. Hence 
Haigis et al (2006) suggests that the change in this ratio 
may downregulate SIRT4 during CR as SIRT4 is 
dependent on NAD for its activity. In addition, SIRT4 






























(MCD1) and deletion of SIRT4 would therefore prevent 
production of a key precursor for fat synthesis (i.e. 
malonyl CoA) [102]. Hence SIRT4 downregulation 
during CR is linked to the changes in energy 
metabolism. SIRT7 was also negatively correlated with 
increasing levels of CR in our study. SIRT7 is mainly 
linked to maintenance of genome integrity and is 
associated with RNA polymerase I [103,104]. SIRT7 is 
highly expressed in tissues with dividing cells [104] and 
it was suggested that SIRT7 activity may be decreased 
during CR to restrain ribosome biogenesis and cell 
growth when energy is limited [105]. Short term 40% 
 
Figure 11. Association between physiological/behavior
data  and  expression  levels  of  genes  involved  in
substrate  metabolism.  Previously  measured  leptin    and
insulin  levels,  food  anticipatory  activity  (FAA),  body





and  the  measured  physiological/behavior  data  while  green
indicates a positive correlation. 
Figure  12.  Hydrogen  Sulfide  production  constructed  in
Ingenuity  Pathway  Analysis  (IPA,  www.qiagen.com/
ingenuity) program. The normalized counts for each gene were
correlated  with  the  increase  in  calorie  restriction  (CR)  level  by
Pearson  correlation method. The pathway  is  colored based on a
cut‐off of an absolute correlation coefficient higher than 0.3. Red
indicates  a  positive  correlation  with  increasing  CR  level  while
green indicates a negative correlation. 
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CR (30 days) had no impact on expression levels (both 
mRNA and protein) of hepatic SIRT7 of 4 months old 
and 24 months old Wistar rats [106]. However, after 3 
months of CR we did found lower expression levels of 
SIRT7 with increasing levels of CR.  
 
Insulin/IGF-1 and NF-ĸB pathways were strongly 
down-regulated at the transcriptional level in relation to 
CR. For mTOR there was some evidence of down-
regulation. Although SIRT4 and SIRT7 was negatively 
correlated with the increase in CR, their role regulating 
lifespan are limited. Hence we postulate that SIRT 
signaling is not necessary for the benefical effects of 










































CR altered fuel utilization that may reduce ROS 
production, and antioxidant defenses  
 
When mice were exposed to long-term CR (28 months) 
changes were found in the TCA cycle intermediates 
which might reflect an important adaptation to create 
available substrates for gluconeogenesis [107]. Levels 
of citrate, glutamate and alpha-ketoglutarate were 
decreased and levels of malate were increased [107]. 
Here we showed gluconeogenesis was increased under 
graded CR, which is in agreement with previous studies 
[108]. We found strong transcriptional upregulation of 
genes linked to glycolysis, the TCA cycle and the 










































Figure  13.  Xenobiotic  metabolism  obtained  from  the  Ingenuity  Pathway  Analysis  (IPA,  www.qiagen.com/ingenuity)
program. The normalized counts for each gene were correlated with the increase in calorie restriction (CR) level by Pearson correlation
method.  The  pathway  is  colored  based  on  a  cut‐off  of  an  absolute  correlation  coefficient  higher  than  0.3.  Red  indicates  a  positive
correlation with increasing CR level while green indicates a negative correlation. 
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for an increased level of metabolism at the tissue level. 
This response is paradoxical because at the whole 
animal level there is less energy being supplied when 
mice are under restriction and hence there is a need to 
reduce energy expenditure at the whole animal level. 
These observations can be reconciled if the animal 
under CR disproportionately reduces the amount of 
tissues in its body to more than compensate for the 
reduced energy intake, providing scope to elevate the 
tissue level of expenditure [109,110]. For the same 
individual mice studied in the present paper we have 
shown that the level of basal metabolic rate [21] is 
consistent with the measured changes in body 
composition at the end of the restriction period [15]. In 
fact,  the  increased  gene  expression  in  the  glycolysis/ 
TCA cycle/ETC was negatively correlated with the 
measured BMR and average body temperature (Figure 
11). The reported transcriptional changes  in  glycolysis/ 
TCA cycle/ETC may then be more important to support 
changes in physical activity patterns. Supporting this 
view, in these same individual mice there was an 
intense period of physical activity prior to food being 


































and transcriptional changes in the glycolysis/TCA 
cycle/ETC cycle were strongly positively correlated 
with the levels of FAA in the same individual mice 
(Figure 11). 
 
One of the earliest theories of aging is that the 
accumulation of damage caused by ROS, via electron 
leakage from the ETC, leads to a gradual decline in 
cellular function [34]. We also found a shift toward 
fatty acid β-oxidation, which produces FADH thereby 
potentially mitigating ROS production [33]. After only 
6 weeks of CR, H2O2 production (i.e. a component of 
the ROS) in hepatic mitochondria of rats significantly 
decreased. Although ROS production was decreased at 
complex I in CR rats, this was not significant compared 
to complex II [111]. Long term CR significantly 
decreased H2O2 production by 46% in hepatic 
mitochondria of rats at complex I [112]. In the present 
analysis transcription of elements of both complex II 
and complex IV were positively correlated with 
increasing CR. A decrease in the capacity of the later 
enzymes in the ETC can theoretically lead to 


































Figure 14.  Integrated overview of  the different  theories of ageing affected by graded calorie
restriction  (CR). Red  indicates a positive  correlation with  increasing CR while blue  indicates a negative
correlation. Grey  indicates no  linear changes with the  increase  in CR  level. Genes or processes biologically
related are grouped together indicated by a yellow box including the insulin/insulin like growth factor (IGF‐
1) signaling pathway, mechanistic target of rapamycin (mTOR) pathway, fuel utilization and autophagy. 
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increasing ROS production [113]. In mammalian brain 
and synaptic mitochondria of rats, decreased activity of 
complex IV was found with age [113,114]. In 
agreement with our results, previous studies have 
reported an increase in complex IV levels under CR in 
brain [115]. 
 
To further elaborate on the ROS theory, we previously 
measured the hepatic activity levels of enzymatic 
antioxidants (i.e. superoxide dismutase (SOD), 
glutathione peroxidase and catalase) [15] in livers of the 
same mice used in the present study. With increasing 
CR these three antioxidants had lower activity levels, 
which is potentially an adaptive response to the 
suggested reduction in ROS production under CR. This 
is also consistent with the fact that oxidative damage 
was unchanged in the same mice [15]. These data are 
consistent with the mice modulating their oxidative 
defense under CR, potentially to save energy, while 
maintaining damage levels constant. 
 
We also investigated other pathways related to ROS and 
found eIF2 signaling was positively correlated and 
NRF2 negatively correlated with the level of CR. In 
response to cell stress eIF2 is phosphorylated and 
reduces formation of the eIF2-GTP complex. This 
lowers general translation and allows the cell to 
selectively enhance gene-specific translation [116]. 
Reduced translation of target genes by phosphorylated 
eIF2 can lower IĸB, which as noted above is an 
inhibitor of NF-ĸB [117]. The upregulation of eIF2 
signaling is inconsistent with the reduced ROS 
production and decreased levels of NF-ĸB observed 
here. However, phosphorylation of eIF2 may be a direct 
effect of CR. Western blots showed that eIF2 is 
phosphorylated to signal nutrient deficiency in the 
anterior piriform cortex of the brains of rats to induce a 
behavior response [118]. Although, eIF2 was up-
regulated in liver, it may reflect the response to state of 
decreased nutrient availably and not a response to 
cellular oxidative stress. NRF2 signaling, the second 
ROS-associated pathway in our data, induces 
expression of genes related to the anti-oxidant response 
(reviewed in [119]). This pathway is activated as a 
cellular defense mechanism against oxidative stress 
[120] and its observed downregulation in relation to 
graded CR would be consistent with reduced ROS 
production. Hence, the changes in NRF2 but not eIF2 
signaling induced by graded CR are in agreement with 
the previously measured reduced activity levels of the 
enzymatic anti-oxidants. 
 
Overall, the changes we observed in genes related to 
fuel utilization may contribute to reduced ROS 
production. However, the responses to this reduction 
including reduced defense, resulted in minimal impact 
on oxidative damage. Hence, these changes are unlikely 
to contribute significantly to the observed increased 
lifespan by CR. However, recent work has highlighted a 
role for solute carrier family 13 (sodium-dependent 
citrate transporter), member 5 (SLC13A5) in whole 
body lipid and glucose metabolism during ageing [121]. 
Liver specific knockdown of SLC13A5 in rats improves 
insulin sensitivity, reduces plasma insulin, lipid and 
amino acid levels, and mediates a trend towards 
decreased basal metabolic rates [121]. Hence SLC13A5 
may be an interesting focus for future longevity studies. 
 
CR impacted MUPs genes and suggested a reduced 
reproductive investment 
 
The disposable soma theory postulating a trade-off 
between investment in somatic maintenance and 
reproduction closes the gap between mechanistic and 
evolutionary theories of aging. In a natural environ-
ment, too high investment in somatic maintenance is not 
beneficial if the organism dies from extrinsic mortality 
before it can breed, while too low protection might 
result in premature death. The disposable soma theory 
argues that during CR organisms need to reallocate the 
limited energy sources to maintain the soma and this 
requires diversion of resources away from reproduction 
[31,32]. MUPs are used in scent marking, and can bind 
molecules that are pheromonally active but are also 
used as signaling molecules. Male mice produce on 
average three to four times more urinary MUPs than 
female mice [62]. More than 99% of urinary proteins 
are MUPs. MUPs are primarily produced in the liver 
and about 20-30% of all the proteins produced by the 
liver in male mice are MUPs [122]. Hence production 
of MUPs is likely to be energetically costly and 
reducing their production may conserve energy for 
allocation to somatic protection [31,62,63]. Gene 
expression for 16 different MUPs were all down-
regulated at 20CR, 30CR and 40CR compared to 12AL 
consistent with previous data showing decreased levels 
of urinary MUPs under CR in the same individual mice 
[15] and another study of mice under CR [63]. We have 
also shown that gene expression of MUPs in adipose 
tissue of the same individuals studied here was also 
reduced [123]  
 
CR had a positive impact on autophagy  
 
During CR autophagy improves cellular survival and 
prevents cell death [124]. Previous work in humans has 
suggested that long-term CR leads to increased 
expression levels of autophagy related genes in skeletal 
muscle [125]. CR-induced autophagy leads to mice 
being more tolerant against chemotherapy induced cell 
damage [126]. Hence the beneficial effects of auto-
phagy under CR seems to come in part from its ability 
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to reduce the accumulation of damaged proteins. In 
addition, aging leads to damaged mitochondrial DNA 
(potentially ROS induced) and autophagy may remove 
these dysfunctional mitochondria [127]. In the present 
study, expression levels of 8 genes involved in 
autophagy were positively associated with the level of 
CR. When ATG7 is repressed in livers of lean mice, 
they develop severe insulin resistance [128], which also 
suggests a role for autophagy in insulin action. 
Circulating levels of insulin of the same mice indeed 
correlated with expression levels of genes involved in 
autophagy but not with Atg7. Hence increased 
autophagy may contribute to the improved insulin 
sensitivity we observed in these animals [15]. 
 
Graded CR had a graded protective effect against 
cancer 
 
A large impact of short-term CR was found on cancer-
related pathways. The beneficial effects of CR on 
cancer are well known and has been reported 
extensively (reviewed in [53]). We observed reduced 
signaling of Hedgehog, TGF-β and CTNN-β with 
increasing CR. Hedgehog signaling plays a role in 
differentiation and determination of cell fate [129]. 
Inhibition of Hedgehog proteins in mice leads to 
decreased propagation of chronic myelogenous 
leukemia [130] and Hedgehog proteins are known to co-
express with other oncogenetic pathways such as TGF-β 
and WNT signaling [131]. It has been proposed that 
leptin (strongly reduced in our mice with increasing CR 
levels [15]) plays an important role as a cell fate 
modulator via Hedgehog signaling in liver fibrosis and 
obesity-associated cancer metastasis [132]. TNF-α is 
known to stimulate TGF-β gene expression, and TGF-β 
is released by adipocytes [133]. TNF-α also had 
progressively reduced circulating levels as severity of 
CR increased [15]. Previous analysis of putative 
signaling proteins secreted by adipose tissue in the same 
mice included those related to TGF-β signaling [123]. 
Hence this may result in reduced TGF-β signaling to 
other tissues, which was in agreement with our hepatic 
results. Excess adipose tissue leads to increased 
secretion of IGF-1, IL6, leptin and TGF-α which can 
promote tumor growth [134,135]. Fat mass and 
circulating levels of IGF-1, IL6 and leptin were all 
reduced in the same mice in a linear manner to the level 
of CR [15]. 
 
The altered hepatic gene expression indicated a 
progressively increased protective effect of graded CR on 
cancer development, which is in agreement with a graded 
decrease in factors promoting tumor growth such as 
circulating leptin levels and fat mass in the same mice. 
Hence, the protective effect of graded CR on cancer 
development may result from a system-wide adaptation. 
CR had no impact on FGF21 and had a positive 
impact on H2S  
 
FGF21 is a hormone secreted by liver during fasting, 
and can induce hepatic fatty acid β-oxidation and 
ketogenesis. In mice, overexpression of FGF21 leads to 
an increased lifespan without reducing food intake [54]. 
Zhang et al. postulated that FGF21 primarily acts by 
blunting the growth factor/IGF-1 signaling pathway 
[54]. Although fatty acid β–oxidation and ketogenesis 
were increased and IGF-1 signaling decreased, we did 
not observe any increase in gene expression of Fgf21 in 
relation to restriction level. This is in stark contrast with 
protein and methionine restriction (PR and MR) studies 
where Fgf21 expression was significantly increased 
compared to controls [136–138]. Our CR diet protocol 
involved simultaneous reductions in both calorie and 
protein intake [14]. Nevertheless, our diets maximally 
involved 40% protein restriction, while previous PR and 
MR studies that impacted Fgf21 gene expression 
involved restrictions of around 80%. Hence if Fgf21 is 
induced by extremely low protein intake rather than 
reduced calories this may explain the absence of a 
significant upregulation of Fgf21 in our CR study. Since 
CR studies seldom exceed 40% restriction (reviewed in 
[139]) and at this level there is a highly significant 
impact on lifespan, these data suggest Fgf21 is unlikely 
to be a significant mediator of the CR effect on lifespan. 
H2S is responsive to physiological stimuli and plays a 
signaling role in neural transmission, smooth muscle 
relaxation and can regulate release of insulin (reviewed 
in [140]). H2S activity is also related to oxidative stress 
and may play a protective role against oxidative damage 
[141–143]. The two enzymes CSE and CBS are 
necessary for the synthesis of H2S [144] and Cth was 
upregulated under CR but Cbs downregulated. H2S 
production via CBS is dependent on S-adenosyl-
methionine [145] and CSE produces H2S via cysteine or 
homocysteine [146]. Cysteine and homocysteine were 
both upregulated in the liver metabolomics data of the 
same mice [22]. This might suggest more H2S 
production via CSE. Increased H2S production during 
CR induces signaling cascades leading to an activation 
of eIF2a (i.e. phosphorylated eIF2) and repression of 
mTOR [147,148]. This is in concordance with our 
results as we found an increase in eIF2 signaling and a 
decrease in mTORC1 and mTORC2 expression with 
increasing CR levels.  
 
In hepatocytes, H2S may regulate expression of 
circadian clock genes and Sirt1 [66]. We found an 
increased gene expression of the clock genes Cry1, 
Per1 and Per2, which was in agreement with the 
expression levels we found in hypothalamus of the same 
mice [19]. Although the circadian rhythms in older mice 
remain, they lose the ability to synchronize with the 
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environment which has a negative effect on longevity 
[149,150]. CR synchronizes these rhythms and may 
protect against the loss of circadian rhythm 
synchronization [151]. Although circadian rhythms are 
mainly established in the suprachiasmatic nucleus 
clock, the central pacemaker in the hypothalamus, 
studies have suggested that expression of circadian 
clock genes in the liver could be established 
independent of the hypothalamus [152–154]. Per1 and 
Per2 have tumor suppression activity [155], which may 
tie in with the anti-cancer mechanism under CR [53]. 
Overall our data are consistent with H2S signaling 
playing a key role in the impact of CR. 
 
CR leads to up regulation of the xenobiotic 
metabolism 
 
Genes in this pathway play an important role in 
protection against environmental toxins and furthermore 
interact with phase II conjugation enzymes, which 
enhance hydrophilicity and excretion rate of 
environmental toxins [156]. These toxins are then 
excreted into bile via downstream phase III transporters 
[156]. Interestingly, long-lived ‘Little’ mice show 
resistance to oxidative toxins, and xenobiotic 
metabolism is upregulated, specifically xenobiotic 
detoxification genes [157,158]. With age, genes 
involved in xenobiotic metabolism are decreased in 
expression [159] and therefore preserved xenobiotic 
metabolism is believed to contribute to the increase in 
lifespan observed in long-lived mice. Similar to Ames 
dwarf and Little mice, our data showed upregulation of 
genes involved in xenobiotic metabolism under graded 
CR relative to 12AL which corresponded with previous 
research focused at single levels of restriction 
[101,160]. The decreased ability of the liver to 
metabolize drugs is believed to be mainly due by loss of 
expression of cytochrome P450 family 2B and 2C, 
which were among the genes significantly upregulated 
in our dataset [161]. Furthermore our data also showed 
genes involved in the ‘FXR/RXR activation’ pathway 
were upregulated as a response to CR, which are 
primary regulators of xenobiotic metabolism [162]. The 
bile acid receptor FXR could potentially mediate the 
upregulation of xenobiotic genes in the long-lived Little 
mice [158]. Although no causal link has been found 
between increased xenobiotic metabolism activity and 
pro-longevity, a study in C. elegans supports such a 
hypothesis [56]. It is still unclear how xenobiotic 
metabolism can increase lifespan but potentially it could 
be as simple as the reduction in damage caused by toxic 
compounds. The beneficial effects of xenobiotic 
metabolism may be signaled via reduced insulin/IGF-1 
signaling under CR. Genes regulated by the 
insulin/IGF-1 pathway in C. elegans include the xeno-
biotic detoxification genes [56]. Microarray analysis in 
long-lived Ames dwarf mice and Little mice suggest a 
similar role for insulin and IGF-1 in regulating 
xenobiotic metabolism [157]. It has been postulated that 
xenobiotic metabolism may be a key modulator of 
aging, separate from oxidative stress [56]. 
 
MATERIALS AND METHODS 
 
Animals and experimental manipulations 
 
All procedures were approved by the University of 
Aberdeen ethical approval committee and carried out 
under the Animals (Scientific Procedures) Act 1986 
Home Office license (PPL 60/3706 held by JRS). Forty 
eight male C57BL/6 mice (Mus musculus) purchased 
from Charles River (Ormiston, UK) were individually 
housed with free access to water. Mice were exposed to 
12 hour dark/light cycle (lights on at 0630h) and body 
mass and food intake were recorded daily, immediately 
prior to nocturnal feeding. At 20 weeks of age 
(resembling early adulthood in human), mice were 
randomly allocated into 6 different treatment groups: 
(12AL n=8, 24AL n=8, 10CR n=8, 20CR n=8, 30CR 
n=7, 40CR n=9). Mice in 24AL and 12AL group were 
fed ad libitum for 24h or 12h during the dark period 
respectively. 10CR, 20CR, 30CR and 40CR indicates 
10 %, 20 %, 30 % and 40 % lower calories respectively 
than their own individual intakes measured over a 
baseline period of 14 days prior to introducing CR. 
 
Animals fed completely ad libitum (i.e., having 24 
hours access to food) may over feed and become obese. 
CR associated changes compared to 24AL are therefore 
most likely to reflect the anti-obesity effect of CR 
[4,163]. In addition, CR-restricted mice generally 
consume food during the first few hours of food 
provided. The 24AL animals can by definition eat at 
any time throughout a 24h period. Hence, when CR-
restricted mice were culled they may have been starving 
for 10h-16h while 24AL may have eaten in the hour 
prior to culling. To address this issue, 12AL was set as a 
reference to avoid the “time since last meal effect” and 
graded levels of CR were introduced to investigate a 
potential graded response. Information on overall study 
design, diet composition and detailed rationale are 
described elsewhere [14]. 
 
RNA isolation, cDNA synthesis and RNA sequencing 
 
After culling by a terminal CO2 overdose the liver was 
removed as part of the overall dissection [14], weighed, 
divided into 7 pieces which were immediately snap 
frozen in liquid nitrogen and stored in -80°C until one 
piece was used for RNA isolation. RNA was isolated by 
homogenizing in Tri-Reagent (Sigma Aldrich, UK) 
according to manufacturer’s instructions. Prior to RNA 
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quantification by Agilent RNA 6000 Nano Kit samples 
were denatured at 65 °C. RNA of 37 individual mice 
was successfully isolated and sent to Beijing Genomic 
Institute (BGI, Hong Kong) for RNA sequencing. 
 
Library preparation was conducted by enriching total 
RNA by using oligo(dT) magnetic beads. The 
fragmentation buffer was added to obtain short 
fragments from the RNA. The mRNA was used as 
template for the random hexamer primers which 
synthesizes the first strand of cDNA. The second strand 
was synthesized by adding buffer dNTPs, RNase and 
DNA polymerase. QiaQuick PCR extraction kit was 
used to purify the double stranded cDNA and washed 
with an elution buffer for end repair and single 
nucleotide A addition. The fragments were ligated with 
sequencing adaptors and purified by agarose gel-
electrophoresis to obtain the correct fragments. These 
were enriched by PCR amplification. During the quality 
control step, Agilent 2100 Bioanalyser and ABI 
StepOnePlus Real-Time PCR System are used to 
qualify and quantify of the sample library. The library 
products were sequenced using an Illumina Hi-seq 2000 
resulting in 50 bp single ended reads (standard protocol 
BGI, Hong Kong). Standard primers and barcodes 
developed by BGI were used. 
 
Alignment to the reference genome 
 
Prior to alignment to the reference genome, FASTQ 
files were quality controlled to identify the presence of 
adaptors or low quality sequences using fastQC 
(http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/)
. To ensure high sequencing quality, the reads were 
trimmed with a cut-off phred score of 28 using 
Trimmomatic [164]. Reads were aligned to the 
reference genome obtained from the National Center for 
Biotechnology Information (NCBI) database (Mus 
musculus, version MGSCv37, 2010/09/23, 
http://www.ncbi.nlm.nih.gov/assembly/165668/). The 
reference genome was indexed using Bowtie2 [165] and 
reads aligned with Tophat2 [166] using default settings. 
Of the 492,199,393 reads 482,311,031 (97.99%) were 
successfully aligned to the reference genome. 15.6 % 
contained multi mapped reads which were removed 
using the Sequence Alignment/Map (SAM) tool [167] 
before proceeding to quantification of the reads. 
Aligned sequencing reads were counted with HTSeq-
count [168] by identification of how many reads 




To remove any genes that exhibited no or a very low 
number of mapped reads, only genes that had more than 
1 count per million in at least 4 samples across all 
treatments were retained for further analysis. This 
resulted in a total of 12,183 unique genes. Read counts 
were normalized using the trimmed mean of M values 
(TMM normalization) [169] to account for highly 
expressed genes consuming a substantial proportion of 
the total library size. This composition effect would 
cause remaining genes to be under sampled [170]. 
Differential gene expression was modeled using the 
edgeR package [170] in R (version 3.1.2) [171] and 
pairwise comparisons were conducted between 12AL 
and 24AL and between 12AL and each level of CR. 
Significant genes were identified based on a cut off p-
value < 0.05 and an absolute log fold change (log FC) 
of 1. We identified differentially expressed genes 
(DEGs) relative to 12AL based on the adjusted p-value 
(FDR < 0.05). At 24AL, 10CR and 20CR none of the 
genes were differently expressed relative to 12AL. At 
30CR only four genes had a FDR lower than 0.05 and at 
40CR this massively increased to 855. We therefore 
used a cut-off value of absolute log2 fold changes (log 
FC) > 1.00 and p-value < 0.05. The amount of DEGs 
relative to 12AL responded to CR in a graded manner 
(24AL, 10CR, 20CR, 30CR and 40CR): 88, 138, 533, 




The normalized counts for each gene were correlated 
with the increase in CR level by Pearson correlation 
method in the statistical environment R (version 3.1.2) 
[171]. The correlation coefficient for all genes 
(n=12,183) and their associated logFC relative to 12AL 
was then loaded into the IPA program (version 2000-
2016, Ingenuity® Systems, www.ingenuity.com) to 
visualize the associated changes with CR in the aging 
pathways. The insulin/IGF-1 signaling pathway was 
constructed by merging the “Insulin Receptor 
Signaling” and “IGF-1 signaling”. For the mTOR 
signaling pathway, the “mTOR signaling” was used. 
The pathways “NF-ĸB Signaling” and “NF-ĸB 
Activation by Viruses” were merged to obtain the NF-
ĸB signaling pathway. IPA did not have a prebuilt 
sirtuin signaling pathway. We therefore manually 
constructed this pathway based on the summarized data 
by Nakagawa and Guarente (2011) [61]. The sirtuin 
signaling pathway was manually constructed by using 
the built-in Path Designer function. For the oxidative 
stress pathway, pathways classified as “Cellular Stress 
and Injury” were merged with the pathway “Production 
of Nitric Oxide and Reactive Oxygen Species in 
Macrophages”. The reproduction pathway was built by 
merging “Germ Cell-Sertoli Cell Junction Signaling”, 
“Sertoli Cell-Sertoli Cell Junction Signaling”, MUP 
genes and the function reproduction. For the cancer 
signaling, autophagy pathway and xenobiotic 
metabolism, the “Molecular Mechanism of Cancer”, 
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“Autophagy”, “Xenobiotic Metabolism Signaling” were 
used. For the changes in fuel utilization, the pathways 
“Glycolysis I”, “TCA cycle II (Eukaryotic)”, “Fatty 
Acid β-oxidation I” and “Gluconeogenesis I” were 
used. Mitochondrial biogenesis was obtained by 
merging “Mitochondrial Dysfunction” and the function 
mito-chondrial biogenesis. Lastly the H2S pathways 
were manually constructed. The p-value is calculated 
using the right-tailed Fisher Exact Test. The z-score 
predicts the activation state (i.e. increased or decreased) 
of a pathway based on the significant patterns that 
match the curated knowledge of gene expression levels 
and the causal relations with the pathway. Hence a 
pathway may have a significant p-value but lack a z-
score if the expression levels of genes does not match 
the pre-defined associated regulation in that particular 
pathway. The custom built pathways do not have a z-
score and hence we do not have a prediction of their 
down or upregulation calculated by IPA. Physiological 
data and behavior al data (methods and data described 
in [15,16,18,21]) were correlated with each gene and 
each individual using Pearson correlations conducted in 
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4E-BP1 Eif4ebp1 -0.227 -0.055 0.711 0.056 0.689 -0.305 0.043 -0.295 0.026 
ACLY Acly -0.339 -1.654 0.002 -1.324 0.007 -0.787 0.124 -1.310 0.003 
AFX Foxo4 -0.308 -0.115 0.519 -0.305 0.073 -0.185 0.301 -0.261 0.098 
BAD Bad 0.476 -0.024 0.925 0.089 0.711 0.240 0.339 0.415 0.062 
c-FOS Fos 0.121 -1.152 0.104 0.271 0.656 -0.193 0.770 0.217 0.705 
c-JUN Jun -0.025 -0.027 0.943 0.834 0.017 -0.052 0.891 -0.014 0.966 
c-RAF Raf1 -0.299 -0.165 0.253 -0.215 0.116 -0.278 0.055 -0.247 0.052 
C3G Rapgef1 0.321 0.178 0.169 0.258 0.036 0.109 0.400 0.215 0.062 
CASP9 Casp9 -0.257 -0.279 0.109 -0.157 0.336 -0.164 0.344 -0.471 0.002 
CBL Cbl 0.217 -0.226 0.512 0.034 0.916 0.044 0.897 0.089 0.766 
CIP4 Trip10 0.217 0.211 0.281 0.383 0.037 0.256 0.190 0.281 0.107 
eIF4E Eif4e -0.131 -0.018 0.898 -0.044 0.746 0.139 0.325 0.069 0.582 
ELK-1 Elk1 -0.377 -0.063 0.808 0.045 0.852 -0.388 0.142 -0.412 0.077 
FAK Ptk2 -0.093 0.133 0.357 0.032 0.819 -0.038 0.797 0.021 0.873 
FKHRL1 Foxo3 0.168 -0.019 0.924 -0.241 0.220 -0.120 0.562 0.015 0.933 
FYN Fyn -0.297 0.002 0.993 0.118 0.519 0.012 0.953 -0.240 0.171 
GAB1 Gab1 0.370 0.234 0.149 0.187 0.227 0.188 0.248 0.200 0.169 
GLUT4 Slc2a4 0.168 -1.636 0.013 -0.688 0.244 0.257 0.671 -0.059 0.913 
GRB10 Grb10 -0.142 0.242 0.536 0.444 0.231 -0.550 0.178 -0.432 0.224 
GRB2 Grb2 -0.346 -0.098 0.434 0.003 0.982 -0.104 0.405 -0.123 0.266 
IGF-1 Igf1 0.160 0.284 0.223 -0.005 0.983 0.321 0.169 0.053 0.800 
IGF1R Igf1r 0.293 0.371 0.297 0.573 0.088 0.257 0.476 0.693 0.029 
INSR Insr 0.507 0.106 0.572 -0.076 0.670 0.153 0.414 0.245 0.141 
IRS1 Irs1 0.120 -0.229 0.408 -0.191 0.466 -0.129 0.639 0.412 0.089 
JNK1 Mapk8 0.392 0.183 0.239 0.051 0.730 0.211 0.173 0.312 0.023 
LAR Ptprf -0.623 -0.293 0.176 -0.325 0.113 -0.615 0.005 -0.594 0.002 
LIPE Lipe -0.141 -0.183 0.446 -0.270 0.235 -0.265 0.271 -0.431 0.043 
mTOR Mtor -0.119 0.060 0.704 0.159 0.289 0.043 0.787 -0.122 0.384 
NCK Nck1 -0.176 -0.094 0.564 -0.169 0.274 -0.205 0.212 -0.137 0.343 
PDE3B Pde3b 0.488 0.236 0.276 0.162 0.432 0.418 0.053 0.415 0.031 
PDK1 Pdpk1 0.279 0.092 0.564 0.054 0.723 -0.018 0.910 0.220 0.120 
PTEN Pten 0.131 0.001 0.995 -0.097 0.595 0.069 0.717 0.041 0.807 
PTP1B Ptpn1 0.112 0.040 0.799 0.261 0.075 0.112 0.472 0.153 0.266 
PXN Pxn 0.248 -0.126 0.367 0.059 0.652 -0.112 0.424 0.054 0.661 
RAPTOR Rptor -0.214 -0.063 0.667 -0.104 0.450 -0.167 0.254 -0.175 0.176 
RAS 
GAP Rasa1 0.001 0.057 0.695 -0.090 0.516 -0.034 0.818 -0.048 0.710 
SGK Sgk1 0.108 0.275 0.330 0.580 0.030 0.500 0.075 0.479 0.057 
SHC Shc1 -0.180 -0.091 0.512 0.026 0.845 -0.072 0.607 -0.258 0.036 
SHP2 Ptpn11 0.124 0.155 0.295 0.114 0.418 0.045 0.764 0.179 0.173 
SOCS3 Socs3 -0.221 -0.655 0.148 -0.046 0.913 -0.919 0.045 -0.677 0.086 
SRF Srf -0.308 -0.259 0.175 -0.140 0.434 -0.432 0.026 -0.155 0.353 
STAT3 Stat3 0.227 -0.364 0.151 0.348 0.142 0.043 0.862 0.271 0.223 
STX4 Stx4a -0.442 -0.455 0.021 -0.771 0.000 -0.361 0.065 -0.572 0.001 
SYNIP Stxbp4 -0.129 -0.026 0.941 -0.099 0.763 -0.295 0.406 -0.473 0.134 
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TC10 Rhoq 0.483 0.240 0.171 0.245 0.143 0.319 0.068 0.428 0.006 
TSC1 Tsc1 0.205 -0.028 0.846 -0.272 0.047 0.014 0.922 0.046 0.713 
TSC2 Tsc2 0.011 0.078 0.581 0.119 0.371 0.094 0.503 0.058 0.643 





10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol r logFC p logFC p logFC p logFC p 
4EBP Eif4ebp1 -0.227 -0.055 0.711 0.056 0.689 -0.305 0.043 -0.295 0.026 
ATG13 Atg13 -0.003 -0.132 0.372 -0.241 0.088 -0.143 0.335 -0.097 0.458 
DGKζ Dgkz 0.070 0.067 0.655 0.249 0.080 0.041 0.784 0.090 0.499 
eIF4B Eif4b -0.188 -0.026 0.882 -0.097 0.566 -0.054 0.761 -0.245 0.120 
eIF4E Eif4e -0.131 -0.018 0.898 -0.044 0.746 0.139 0.325 0.069 0.582 
FKBP1 Fkbp1a -0.007 0.028 0.861 0.289 0.054 0.119 0.454 0.089 0.528 
GBL Mlst8 -0.440 0.244 0.367 0.231 0.369 -0.230 0.413 -0.196 0.428 
HIF1α Hif1a 0.060 0.008 0.954 -0.089 0.502 -0.113 0.421 -0.054 0.661 
INSR Insr 0.507 0.106 0.572 -0.076 0.670 0.153 0.414 0.245 0.141 
IRS1 Irs1 0.120 -0.229 0.408 -0.191 0.466 -0.129 0.639 0.412 0.089 
LKB1 Stk11 -0.353 0.037 0.776 -0.073 0.558 -0.158 0.232 -0.165 0.159 
mTOR Mtor -0.119 0.060 0.704 0.159 0.289 0.043 0.787 -0.122 0.384 
p70S6K Rps6kb1 0.112 0.098 0.566 -0.043 0.791 0.022 0.899 0.131 0.384 
PDK1 Pdpk1 0.279 0.092 0.564 0.054 0.723 -0.018 0.910 0.220 0.120 
PKCα Prkca 0.269 0.134 0.509 0.079 0.681 0.151 0.455 0.296 0.099 
PRAS40 Akt1s1 -0.256 -0.189 0.199 -0.139 0.315 -0.208 0.159 -0.257 0.048 
RAC Rac1 -0.077 -0.032 0.801 -0.003 0.981 -0.037 0.773 -0.059 0.604 
RAPTOR Rptor -0.214 -0.063 0.667 -0.104 0.450 -0.167 0.254 -0.175 0.176 
REDD1 Ddit4 0.446 0.176 0.752 0.840 0.106 0.954 0.078 1.777 0.000 
RHEB Rheb 0.222 0.117 0.447 0.184 0.205 0.092 0.548 0.222 0.103 
RICTOR Rictor 0.328 0.312 0.161 0.231 0.276 0.270 0.226 0.332 0.094 
RPS6 Rps6 0.487 -0.032 0.858 0.035 0.839 0.163 0.364 0.268 0.093 
SIN1 Mapkap1 -0.318 -0.018 0.889 -0.119 0.345 -0.118 0.375 -0.131 0.267 
TSC1 Tsc1 0.205 -0.028 0.846 -0.272 0.047 0.014 0.922 0.046 0.713 
TSC2 Tsc2 0.011 0.078 0.581 0.119 0.371 0.094 0.503 0.058 0.643 










r logFC p logFC p logFC p logFC p 
β-TrCP Btrc -0.112 -0.003 0.986 0.009 0.958 0.020 0.913 -0.157 0.337 
A20 Tnfaip3 -0.100 0.218 0.582 0.351 0.349 -0.399 0.334 -0.311 0.389 
ABIN-1 Tnip1 -0.219 -0.115 0.764 0.330 0.358 -0.569 0.146 -0.645 0.059 
Bcl10 Bcl10 0.106 -0.238 0.314 0.110 0.616 0.101 0.663 0.007 0.975 
BIMP1 Card10 0.062 0.207 0.354 0.318 0.132 0.231 0.302 0.120 0.548 
c-RAF Raf1 -0.299 -0.165 0.253 -0.215 0.116 -0.278 0.055 -0.247 0.052 
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CARD11 Card11 -0.294 -0.096 0.883 -0.445 0.479 -0.963 0.166 -1.573 0.013 
Caspase8 Casp8 0.075 0.093 0.508 0.039 0.770 0.047 0.737 -0.072 0.568 
CCR5 Ccr5 -0.087 0.160 0.608 0.536 0.065 0.350 0.258 0.112 0.687 
CD4 Cd4 -0.550 -0.161 0.797 -0.779 0.204 -2.064 0.005 -1.509 0.011 
Cot Map3k8 0.125 -0.422 0.256 -0.131 0.703 -0.368 0.321 -0.050 0.877 
FADD Fadd -0.480 -0.293 0.095 -0.301 0.070 -0.415 0.019 -0.565 0.000 
GSK-3β Gsk3b 0.117 0.144 0.273 0.063 0.614 0.006 0.966 0.095 0.416 
HVEM Tnfrsf14 -0.030 0.162 0.622 0.339 0.270 0.186 0.572 -0.191 0.528 
IKKα Chuk 0.065 0.152 0.458 -0.183 0.349 0.035 0.865 -0.021 0.908 
IKKβ Ikbkb -0.137 -0.011 0.926 -0.068 0.535 -0.054 0.646 -0.124 0.230 
IKKγ Ikbkg -0.099 0.213 0.163 0.202 0.165 -0.021 0.892 0.072 0.599 
IRAK-M Irak3 0.031 -0.275 0.389 -0.126 0.671 -0.430 0.187 0.047 0.865 
JNK1 Mapk8 0.392 0.183 0.239 0.051 0.730 0.211 0.173 0.312 0.023 
LTBR Ltbr -0.028 -0.067 0.630 0.041 0.755 -0.107 0.442 -0.024 0.844 
MALT1 Malt1 -0.026 0.070 0.704 -0.135 0.446 -0.024 0.899 -0.040 0.808 
MEKK1 Map3k1 -0.017 0.233 0.317 0.167 0.452 -0.016 0.946 0.145 0.486 
MYD88 Myd88 0.040 -0.245 0.162 -0.095 0.564 -0.174 0.318 0.009 0.954 
NAK Tbk1 0.311 -0.048 0.771 -0.089 0.570 -0.024 0.883 0.254 0.079 
NAP1 Azi2 0.566 0.166 0.283 -0.040 0.784 0.281 0.067 0.236 0.085 
NF-κB1 
p50 
Nfkb1 -0.133 0.105 0.571 -0.092 0.605 -0.161 0.396 -0.100 0.548 
NF-κB2 
p100 
Nfkb2 -0.234 0.203 0.592 0.479 0.182 -0.394 0.313 -0.734 0.034 
NGF Ngf -0.225 0.430 0.558 0.679 0.333 -0.142 0.850 -0.245 0.711 
NIK Map3k14 0.156 0.511 0.241 1.164 0.004 0.402 0.361 0.667 0.088 
p65/RelA Rela -0.300 -0.150 0.371 -0.134 0.396 -0.409 0.016 -0.292 0.049 
PELI1 Peli1 0.206 0.022 0.896 -0.185 0.247 -0.106 0.527 0.025 0.866 
PKCζ Prkcz -0.322 -0.132 0.538 -0.358 0.081 -0.368 0.089 -0.566 0.003 
PKR Eif2ak2 -0.007 0.058 0.719 -0.039 0.801 0.057 0.727 0.084 0.559 
PLCγ2 Plcg2 -0.289 0.043 0.917 0.196 0.619 -0.318 0.454 -1.239 0.001 
RelB Relb -0.255 0.435 0.434 0.567 0.283 -0.477 0.414 -1.635 0.003 
RIP Ripk1 0.125 0.025 0.864 0.012 0.927 -0.139 0.336 0.063 0.619 
TAB1 Tab1 0.100 0.458 0.179 0.301 0.358 0.341 0.323 0.388 0.207 
TANK Tank -0.150 0.138 0.360 -0.049 0.734 -0.178 0.250 0.035 0.793 
TBP Tbp 0.368 0.146 0.476 0.122 0.531 0.052 0.803 0.443 0.014 
TGF-α Tgfa -0.169 -0.020 0.907 -0.033 0.844 -0.340 0.057 -0.297 0.058 
TIRAP Tirap -0.481 -0.091 0.608 -0.187 0.267 -0.044 0.804 -0.222 0.157 
TRADD Tradd -0.114 -0.526 0.016 -0.135 0.494 -0.100 0.631 -0.240 0.198 
TRAF2 Traf2 -0.004 0.326 0.163 0.400 0.071 0.112 0.638 0.206 0.330 
TRAF6 Traf6 0.420 0.135 0.414 0.082 0.601 0.150 0.365 0.383 0.009 
TTRAP Tdp2 0.498 0.012 0.949 0.050 0.787 0.382 0.047 0.288 0.094 
UBE2N Ube2n -0.386 -0.143 0.276 -0.157 0.209 -0.223 0.092 -0.120 0.302 
UBE2V1 Ube2v1 -0.301 -0.096 0.446 0.027 0.818 -0.069 0.584 -0.080 0.472 





   10CR 20CR 30CR 40CR 
Symbol 
Gene 
symbol r logFC p logFC p logFC p logFC p 
ACADL Acadl 0.763 0.111 0.612 0.263 0.208 0.468 0.032 0.557 0.005 
ARNTL Arntl -0.105 -1.581 0.038 -1.588 0.026 -1.808 0.020 0.261 0.674 
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BIRC5 Birc5 -0.039 0.321 0.580 1.432 0.008 -0.403 0.507 0.053 0.920 
CDKN1A Cdkn1a 0.055 0.775 0.288 1.702 0.016 -0.253 0.736 1.225 0.066 
CPS1 Cps1 0.476 -0.279 0.234 -0.222 0.317 0.030 0.899 0.177 0.392 
CRTC2 Crtc2 0.626 0.135 0.439 0.130 0.432 0.220 0.204 0.463 0.003 
CTNNB1 Ctnnb1 -0.363 -0.100 0.550 -0.083 0.601 -0.220 0.190 -0.268 0.069 
CYC1 Cyc1 0.617 -0.086 0.611 0.020 0.898 0.157 0.349 0.309 0.039 
CYCS Cycs 0.572 0.064 0.782 -0.084 0.702 0.231 0.313 0.523 0.011 
E2F1 E2f1 -0.296 0.182 0.629 0.681 0.050 -0.128 0.741 -0.441 0.210 
EPAS1 Epas1 0.343 -0.396 0.183 -0.125 0.655 0.108 0.714 0.108 0.678 
FOXO1 Foxo1 0.603 0.236 0.302 0.322 0.139 0.382 0.094 0.681 0.001 
FOXO3 Foxo3 0.168 -0.019 0.924 -0.241 0.220 -0.120 0.562 0.015 0.933 
FOXO4 Foxo4 -0.308 -0.115 0.519 -0.305 0.073 -0.185 0.301 -0.261 0.098 
GLUD1 Glud1 0.655 -0.123 0.559 0.047 0.815 0.230 0.271 0.460 0.014 
HIF1A Hif1a 0.060 0.008 0.954 -0.089 0.502 -0.113 0.421 -0.054 0.661 
HNF4A Hnf4a 0.338 -0.104 0.665 0.075 0.744 -0.060 0.802 0.316 0.139 
HSF1 Hsf1 0.015 -0.047 0.744 -0.059 0.666 -0.040 0.782 0.012 0.925 
IDE Ide -0.662 -0.125 0.442 -0.345 0.026 -0.422 0.010 -0.371 0.010 
IDH2 Idh2 0.556 0.443 0.099 0.740 0.004 0.818 0.002 0.850 <0.001 
MRPL10 Mrpl10 -0.223 -0.127 0.302 0.007 0.949 -0.188 0.131 -0.035 0.747 
NDUFA9 Ndufa9 0.506 -0.136 0.385 -0.142 0.340 0.097 0.535 0.240 0.082 
NFKB1 Nfkb1 -0.133 0.105 0.571 -0.092 0.605 -0.161 0.396 -0.100 0.548 
NFKB2 Nfkb2 -0.234 0.203 0.592 0.479 0.182 -0.394 0.313 -0.734 0.034 
NR1H2 Nr1h2 0.381 -0.140 0.341 0.037 0.787 0.101 0.485 0.232 0.069 
NR1H3 Nr1h3 -0.540 -0.134 0.458 -0.134 0.432 -0.152 0.397 -0.344 0.030 
PARP1 Parp1 -0.363 -0.176 0.288 -0.179 0.252 -0.208 0.209 -0.418 0.004 
PER2 Per2 0.724 0.671 0.039 0.828 0.008 1.028 0.002 0.950 0.001 
PIP5K1A Pip5k1a 0.105 -0.069 0.723 0.277 0.121 -0.003 0.988 -0.009 0.960 
PIP5K1C Pip5k1c -0.120 -0.027 0.840 0.135 0.282 -0.001 0.995 0.049 0.676 
PPARA Ppara 0.257 -0.004 0.987 -0.055 0.811 0.114 0.637 -0.037 0.864 
PPARG Pparg -0.012 0.249 0.483 0.534 0.113 0.024 0.947 -0.111 0.729 
PPARGC1A Ppargc1a 0.806 -0.172 0.624 0.249 0.452 0.623 0.071 1.064 0.001 
PPID Ppid -0.654 -0.037 0.856 -0.242 0.208 -0.380 0.063 -0.319 0.074 
RARA Rara -0.358 0.048 0.765 0.051 0.739 -0.203 0.217 -0.363 0.013 
RARB Rarb 0.370 0.166 0.594 0.802 0.005 0.631 0.037 0.646 0.017 
RB1 Rb1 -0.315 0.052 0.757 -0.338 0.039 -0.251 0.146 -0.217 0.153 
RBL1 Rbl1 -0.021 0.645 0.161 0.934 0.032 0.086 0.858 -0.011 0.980 
RBL2 Rbl2 0.562 0.004 0.983 -0.245 0.127 0.051 0.762 0.252 0.090 
RELA Rela -0.300 -0.150 0.371 -0.134 0.396 -0.409 0.016 -0.292 0.049 
SDHA Sdha 0.185 -0.084 0.658 -0.239 0.185 0.027 0.886 0.013 0.937 
SDHB Sdhb 0.462 0.127 0.474 -0.026 0.876 0.195 0.271 0.193 0.220 
SIRT1 Sirt1 0.214 0.016 0.938 0.066 0.732 -0.119 0.560 0.299 0.092 
SIRT2 Sirt2 -0.080 -0.038 0.754 -0.037 0.749 -0.131 0.282 -0.098 0.361 
SIRT3 Sirt3 -0.032 0.028 0.890 -0.262 0.174 -0.003 0.988 -0.233 0.192 
SIRT4 Sirt4 -0.653 0.037 0.882 -0.299 0.216 -0.638 0.017 -0.499 0.030 
SIRT5 Sirt5 -0.297 -0.066 0.770 -0.172 0.422 -0.033 0.884 -0.523 0.010 
SIRT6 Sirt6 0.051 0.203 0.561 0.142 0.669 -0.145 0.687 0.035 0.911 
SIRT7 Sirt7 -0.501 -0.184 0.248 -0.317 0.037 -0.286 0.074 -0.304 0.031 
SLC25A5 Slc25a5 0.732 0.046 0.803 0.165 0.344 0.368 0.044 0.478 0.003 
SMAD7 Smad7 0.052 0.229 0.338 0.123 0.588 0.431 0.069 -0.247 0.254 
SREBF1 Srebf1 -0.463 -0.260 0.435 -0.102 0.745 -0.343 0.304 -0.914 0.002 
SREBF2 Srebf2 0.257 -0.236 0.226 0.115 0.529 0.035 0.855 0.094 0.583 
TLE1 Tle1 -0.153 -0.255 0.141 -0.284 0.083 -0.443 0.011 -0.049 0.746 
TP53 Trp53 -0.159 0.136 0.551 0.326 0.131 -0.272 0.245 -0.076 0.711 
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TSC2 Tsc2 0.011 0.078 0.581 0.119 0.371 0.094 0.503 0.058 0.643 
TUBA1A Tuba1a -0.226 -0.288 0.545 0.102 0.818 -0.756 0.124 -0.799 0.062 
TUBA1B Tuba1b -0.307 -0.171 0.565 0.169 0.541 -0.311 0.301 -0.530 0.047 
TUBA1C Tuba1c -0.377 -0.283 0.481 0.108 0.774 -0.693 0.090 -0.688 0.053 
TUBA4A Tuba4a -0.595 -0.502 0.077 -0.665 0.014 -0.803 0.005 -0.597 0.016 
TUBA8 Tuba8 0.525 1.004 0.123 1.542 0.014 1.050 0.108 2.228 <0.001 
UCP2 Ucp2 -0.133 0.204 0.479 0.582 0.033 0.177 0.540 -0.190 0.458 
WRN Wrn -0.057 0.014 0.930 -0.190 0.222 -0.129 0.430 -0.135 0.351 





10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol r logFC p logFC p logFC p logFC p 
53BP1 Trp53bp1 -0.455 0.142 0.346 -0.124 0.392 -0.160 0.297 -0.182 0.181 
AKR Akr1a1 -0.214 -0.013 0.939 0.062 0.704 -0.016 0.926 -0.083 0.587 
AKT Akt1 0.072 0.049 0.710 0.258 0.038 0.109 0.405 0.046 0.695 
AOX1 Aox1 -0.316 0.156 0.476 0.159 0.446 -0.046 0.835 -0.185 0.343 
ARD1 Naa10 0.052 -0.251 0.082 -0.064 0.633 -0.025 0.861 0.004 0.977 
ARNT Arnt 0.457 0.085 0.566 0.091 0.519 0.273 0.063 0.201 0.126 
ASK1 Map3k5 0.525 0.195 0.382 0.019 0.928 0.152 0.494 0.294 0.137 
ATF2 Atf2 0.414 0.014 0.922 -0.053 0.690 0.046 0.745 0.208 0.093 
ATF4 Atf4 -0.141 -0.061 0.700 -0.055 0.714 -0.034 0.830 -0.161 0.253 
ATF6 Atf6 -0.227 -0.058 0.724 -0.022 0.889 -0.318 0.055 -0.090 0.538 
ATM Atm 0.005 0.105 0.576 -0.050 0.780 0.011 0.954 -0.078 0.646 
BACH1 Bach1 0.070 0.365 0.051 0.088 0.625 0.096 0.610 -0.094 0.573 
BID Bid -0.364 -0.040 0.835 -0.201 0.275 -0.184 0.345 -0.408 0.019 
BIP Hspa5 -0.431 -0.164 0.571 -0.197 0.473 -0.519 0.076 -0.500 0.050 
BLM Blm -0.066 -0.193 0.591 -0.702 0.044 -0.239 0.507 -0.460 0.150 
BRCA1 Brca1 0.463 0.008 0.985 0.734 0.055 0.903 0.024 1.072 0.003 
c-Abl Abl1 0.245 0.189 0.215 0.260 0.071 0.246 0.105 0.122 0.371 
c-Jun Jun -0.025 -0.027 0.943 0.834 0.017 -0.052 0.891 -0.014 0.966 
c-MAF Maf 0.259 0.052 0.748 0.210 0.175 0.236 0.146 0.176 0.223 
c-RAF Raf1 -0.299 -0.165 0.253 -0.215 0.116 -0.278 0.055 -0.247 0.052 
CALR Calr -0.616 -0.562 0.065 -0.444 0.122 -0.902 0.003 -0.638 0.016 
CASP3 Casp3 -0.315 -0.439 0.038 -0.312 0.115 -0.059 0.774 -0.472 0.011 
CASP7 Casp7 0.158 -0.014 0.941 -0.025 0.887 0.268 0.142 -0.086 0.600 
CASP9 Casp9 -0.257 -0.279 0.109 -0.157 0.336 -0.164 0.344 -0.471 0.002 
CAT Cat -0.805 -0.091 0.700 -0.470 0.039 -0.487 0.043 -0.668 0.001 
CBP Crebbp 0.395 0.196 0.375 0.185 0.379 0.138 0.533 0.399 0.042 
CBR1 Cbr1 0.712 0.505 0.221 1.316 0.001 1.314 0.001 1.858 0.000 
CCT7 Cct7 0.068 -0.152 0.253 0.049 0.697 -0.010 0.937 0.005 0.968 
CDC25A Cdc25a 0.175 0.154 0.598 0.426 0.116 0.273 0.348 0.376 0.144 
CDK1 Cdk1 -0.132 0.564 0.430 1.514 0.025 0.445 0.538 -0.742 0.267 
CDK2 Cdk2 0.027 0.145 0.420 -0.176 0.315 0.068 0.709 -0.078 0.631 
Chk2 Chek2 -0.238 0.188 0.623 0.426 0.234 0.330 0.386 -0.226 0.524 
CHOP Ddit3 -0.200 0.635 0.174 0.784 0.079 0.146 0.759 -0.136 0.749 
CLPP Clpp -0.026 -0.128 0.359 -0.074 0.574 -0.092 0.511 -0.004 0.977 
CSF2Rα Csf2ra -0.123 0.121 0.738 0.439 0.197 -0.017 0.962 -0.735 0.026 
CSF2Rβ Csf2rb2 -0.032 0.382 0.327 0.706 0.056 0.191 0.554 -0.029 0.921 
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CUL2 Cul2 -0.524 0.027 0.848 -0.253 0.061 -0.094 0.508 -0.186 0.137 
EIF2S1 Eif2s1 -0.195 0.050 0.740 0.101 0.480 -0.117 0.440 -0.105 0.433 
eIF4E Eif4e -0.131 -0.018 0.898 -0.044 0.746 0.139 0.325 0.069 0.582 
elF2α Eif2a 0.502 0.059 0.628 0.019 0.873 0.161 0.188 0.185 0.089 
elF2γ Eif2s3x 0.426 0.109 0.460 -0.003 0.985 0.159 0.280 0.253 0.054 
elF4C Eif1a 0.038 -0.028 0.906 0.159 0.483 -0.019 0.938 0.221 0.296 
ELK-1 Elk1 -0.377 -0.063 0.808 0.045 0.852 -0.388 0.142 -0.412 0.077 
EPHX1 Ephx1 0.042 0.282 0.421 0.846 0.011 0.418 0.232 0.633 0.044 
ERK5 Mapk7 -0.087 0.035 0.909 0.106 0.709 -0.127 0.682 -0.082 0.765 
ERP29 Erp29 -0.508 -0.227 0.173 -0.084 0.593 -0.293 0.080 -0.313 0.033 
FKBP5 Fkbp5 0.780 0.438 0.411 1.267 0.013 1.575 0.003 2.180 0.000 
FMO1 Fmo1 0.818 0.439 0.149 0.724 0.012 1.206 0.000 1.099 0.000 
FTH1 Fth1 0.532 0.184 0.319 0.283 0.108 0.326 0.077 0.409 0.013 
GADD34 Ppp1r15a 0.191 0.049 0.799 0.170 0.348 -0.004 0.984 0.139 0.416 
GCLC Gclc -0.388 0.246 0.368 0.017 0.948 -0.571 0.041 -0.504 0.038 
GCLM Gclm 0.003 0.221 0.152 0.332 0.024 0.131 0.396 0.160 0.245 
GCN2 Eif2ak4 0.387 -0.003 0.989 0.084 0.635 0.139 0.454 0.300 0.067 
gp91 Cybb -0.071 0.217 0.534 0.732 0.027 0.021 0.951 -0.483 0.120 
GRB2 Grb2 -0.346 -0.098 0.434 0.003 0.982 -0.104 0.405 -0.123 0.266 
GRP94 Hsp90b1 -0.486 -0.287 0.160 -0.337 0.082 -0.370 0.071 -0.302 0.092 
GSK3β Gsk3b 0.117 0.144 0.273 0.063 0.614 0.006 0.966 0.095 0.416 
GSR Gsr -0.153 0.054 0.710 0.121 0.376 -0.187 0.198 -0.034 0.788 
H2AX H2afx -0.111 0.212 0.396 0.289 0.220 -0.184 0.479 0.144 0.523 
HERPUD1 Herpud1 0.184 -0.120 0.645 0.004 0.987 -0.025 0.922 0.216 0.347 
HIF1α Hif1a 0.060 0.008 0.954 -0.089 0.502 -0.113 0.421 -0.054 0.661 
HIP2 Ube2k 0.058 -0.050 0.678 -0.039 0.730 -0.006 0.963 0.124 0.245 
HO-1 Hmox1 0.117 -0.006 0.985 0.739 0.020 -0.080 0.813 0.241 0.418 
HP1 Cbx5 0.205 0.255 0.067 0.183 0.167 0.177 0.204 0.062 0.620 
HRI Eif2ak1 0.151 -0.016 0.903 -0.161 0.192 -0.118 0.363 -0.002 0.989 
HSP90 Hsp90aa1 -0.423 0.055 0.820 0.124 0.588 -0.203 0.404 -0.150 0.483 
IκBα Nfkbia 0.575 0.116 0.557 0.074 0.695 0.160 0.418 0.462 0.008 
ICAM1 Icam1 -0.056 -0.036 0.914 0.411 0.194 0.081 0.809 -0.085 0.775 
ICSBP Irf8 -0.080 0.320 0.324 0.472 0.125 0.093 0.776 -0.458 0.121 
INSR Insr 0.507 0.106 0.572 -0.076 0.670 0.153 0.414 0.245 0.141 
IRE1 Ern1 -0.184 -0.033 0.895 -0.344 0.154 -0.466 0.069 -0.009 0.969 
IRF-1 Irf1 -0.132 -0.040 0.851 -0.090 0.656 -0.261 0.225 -0.208 0.269 
JAB1 Cops5 0.151 -0.080 0.547 -0.069 0.583 0.044 0.739 -0.008 0.945 
JAK2 Jak2 -0.138 0.054 0.707 -0.132 0.337 -0.130 0.368 -0.177 0.167 
JIK Taok3 0.580 0.045 0.804 0.040 0.813 0.101 0.571 0.349 0.028 
JNK1 Mapk8 0.392 0.183 0.239 0.051 0.730 0.211 0.173 0.312 0.023 
KAP-1 Trim28 0.142 -0.072 0.661 0.024 0.880 0.007 0.965 0.005 0.974 
MDC1 Mdc1 0.099 -0.010 0.960 0.079 0.672 0.082 0.680 0.117 0.506 
MDM2 Mdm2 0.001 0.116 0.521 0.217 0.203 0.048 0.791 0.120 0.456 
MDMX Mdm4 0.309 0.298 0.281 0.279 0.289 0.337 0.222 0.311 0.207 
MEK1 Map2k1 -0.493 -0.174 0.283 -0.122 0.426 -0.182 0.262 -0.359 0.012 
MEK5 Map2k5 0.099 -0.098 0.545 0.004 0.978 -0.200 0.220 -0.058 0.687 
MEKK Map3k1 -0.017 0.233 0.317 0.167 0.452 -0.016 0.946 0.145 0.486 
MRE11 Mre11a 0.072 0.142 0.625 0.123 0.657 -0.236 0.435 0.075 0.773 
MRP1 Abcc1 -0.030 0.317 0.441 0.360 0.357 -0.148 0.727 -0.369 0.329 
MRP2 Abcc2 0.241 0.209 0.333 0.190 0.355 0.132 0.543 0.139 0.470 
MRP4 Abcc4 0.073 1.657 0.007 2.157 0.000 0.988 0.108 1.217 0.030 
NBS1 Nbn 0.141 0.014 0.925 -0.089 0.534 -0.079 0.604 0.024 0.857 
NRF2 Nfe2l2 -0.139 -0.035 0.828 -0.105 0.491 -0.146 0.365 -0.057 0.687 
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NRPB Enc1 0.455 0.275 0.558 1.004 0.024 0.988 0.033 1.406 0.001 
p21CIP1 Cdkn1a 0.055 0.775 0.288 1.702 0.016 -0.253 0.736 1.225 0.066 
p22phox Cyba -0.101 0.115 0.767 0.647 0.075 0.062 0.874 -0.394 0.258 
p38MAPK Mapk14 0.614 0.219 0.157 0.243 0.099 0.306 0.048 0.436 0.002 
p40phox Ncf4 -0.231 -0.210 0.679 0.161 0.733 -0.169 0.739 -1.054 0.025 
p47phox Ncf1 -0.150 0.301 0.338 0.621 0.036 -0.082 0.799 -0.444 0.123 
p53 Trp53 -0.159 0.136 0.551 0.326 0.131 -0.272 0.245 -0.076 0.711 
P58IPK Dnajc3 -0.105 -0.070 0.703 -0.144 0.409 -0.119 0.518 0.083 0.609 
p67phox Ncf2 -0.112 -0.069 0.857 0.271 0.447 -0.019 0.960 -0.427 0.210 
PABP Pabpc1 -0.272 0.045 0.775 0.011 0.944 -0.191 0.230 -0.180 0.200 
PAI-1 Serpine1 0.039 -0.037 0.954 0.875 0.140 0.254 0.687 -0.365 0.521 
PDK1 Pdpk1 0.279 0.092 0.564 0.054 0.723 -0.018 0.910 0.220 0.120 
PERK Eif2ak3 -0.206 0.109 0.663 -0.187 0.438 -0.587 0.024 -0.329 0.145 
PKCβ Prkcb -0.177 -0.169 0.508 0.129 0.589 -0.223 0.385 -0.648 0.005 
PKR Eif2ak2 -0.007 0.058 0.719 -0.039 0.801 0.057 0.727 0.084 0.559 
PMF-1 Pmf1 0.453 -0.372 0.063 -0.128 0.491 0.074 0.702 0.211 0.221 
PPARα Ppara 0.257 -0.004 0.987 -0.055 0.811 0.114 0.637 -0.037 0.864 
PPIB Ppib -0.602 -0.394 0.099 -0.258 0.252 -0.507 0.034 -0.526 0.012 
PRDX1 Prdx1 -0.201 -0.130 0.457 -0.079 0.632 -0.058 0.738 -0.078 0.610 
Rac1 Rac1 -0.077 -0.032 0.801 -0.003 0.981 -0.037 0.773 -0.059 0.604 
Rad50 Rad50 0.066 0.028 0.870 0.108 0.508 0.063 0.714 -0.009 0.956 
RAD9 Rad9a 0.112 0.093 0.512 0.175 0.191 0.048 0.735 0.033 0.792 
REF1 Apex1 -0.363 -0.469 0.021 -0.188 0.323 -0.298 0.140 -0.469 0.009 
SHC Shc1 -0.180 -0.091 0.512 0.026 0.845 -0.072 0.607 -0.258 0.036 
SIRPα Sirpa -0.184 0.119 0.738 0.451 0.180 -0.253 0.481 -0.597 0.059 
SP1 Sp1 -0.145 -0.081 0.528 -0.179 0.146 -0.215 0.100 -0.138 0.228 
SQSTM1 Sqstm1 -0.287 0.000 0.999 0.200 0.481 -0.483 0.110 -0.475 0.072 
SR-BI Scarb1 0.155 -0.154 0.397 0.015 0.930 -0.146 0.422 0.125 0.438 
SRC-1 Ncoa1 0.269 -0.018 0.903 -0.090 0.507 0.104 0.465 0.194 0.123 
STAT1 Stat1 -0.217 0.044 0.866 0.120 0.631 -0.417 0.116 -0.336 0.148 
STIP1 Stip1 -0.520 -0.131 0.496 -0.084 0.646 -0.361 0.064 -0.289 0.089 
TCEB1 Tceb1 -0.252 0.119 0.519 0.005 0.978 0.076 0.682 -0.016 0.922 
TDP1 Tdp1 -0.089 -0.083 0.827 0.200 0.569 0.005 0.990 -0.327 0.339 
TLR4 Tlr4 -0.006 -0.007 0.979 0.146 0.576 0.044 0.875 0.005 0.986 
TPA Plat -0.148 0.369 0.658 0.767 0.334 -1.024 0.248 -1.440 0.064 
TRAF2 Traf2 -0.004 0.326 0.163 0.400 0.071 0.112 0.638 0.206 0.330 
TRXR1 Txnrd1 -0.057 0.190 0.296 0.174 0.314 -0.053 0.773 0.134 0.405 
TXN Txn1 -0.298 -0.127 0.418 -0.351 0.019 -0.176 0.265 -0.196 0.157 
UB2R1 Cdc34 -0.111 0.082 0.607 0.241 0.108 -0.105 0.512 0.053 0.707 
UbcM2 Ube2e3 0.477 -0.026 0.855 0.063 0.640 0.154 0.275 0.241 0.054 
USP14 Usp14 -0.191 -0.044 0.732 -0.114 0.352 -0.041 0.750 -0.039 0.734 
VCAM1 Vcam1 0.456 0.122 0.711 0.847 0.007 0.542 0.097 0.639 0.029 
VCP Vcp -0.549 -0.369 0.088 -0.321 0.116 -0.538 0.013 -0.542 0.004 
VHL Vhl -0.256 0.052 0.835 0.116 0.621 -0.004 0.986 -0.045 0.838 



































ACOX1 Acox1 0.368 0.052 0.793 0.115 0.541 0.242 0.221 0.079 0.653 
AHR Ahr 0.468 
-
0.012 0.957 0.117 0.564 0.293 0.166 0.422 0.025 
AKT1 Akt1 0.072 0.049 0.710 0.258 0.038 0.109 0.405 0.046 0.695 
Apaf1 Apaf1 0.020 0.141 0.693 0.775 0.018 0.373 0.290 0.037 0.908 
ASPH Asph 
-







ATF2 Atf2 0.414 0.014 0.922 
-
0.053 0.690 0.046 0.745 0.208 0.093 
ATM Atm 0.005 0.105 0.576 
-
0.050 0.780 0.011 0.954 
-
0.078 0.646 
ATR Atr 0.422 0.237 0.206 0.302 0.089 0.340 0.068 0.422 0.011 

























0.005 0.134 0.473 0.224 0.205 
-
0.077 0.684 0.065 0.695 




































0.154 0.366 0.177 0.315 0.024 0.881 
CDK2 Cdk2 0.027 0.145 0.420 
-




































0.238 0.188 0.623 0.426 0.234 0.330 0.386 
-
0.226 0.524 
CK1δ Csnk1d 0.154 
-
0.057 0.648 0.067 0.570 
-
0.100 0.426 0.148 0.179 
CTNNγ Jup 0.163 
-
0.203 0.247 0.307 0.062 0.136 0.433 0.171 0.266 
CyclinG Ccng1 
-
0.121 0.068 0.665 0.035 0.813 0.079 0.616 
-
0.107 0.447 
CyclinK Ccnk 0.409 
-
0.082 0.576 0.076 0.579 0.004 0.976 0.138 0.282 
Cyclin D1 Ccnd1 0.103 0.588 0.224 1.520 0.001 1.324 0.006 0.226 0.601 
Cyclin D2 Ccnd2 - 0.264 0.353 0.128 0.637 - 0.555 - 0.026 
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DRAM Dram1 0.084 
-






























0.093 0.133 0.357 0.032 0.819 
-
0.038 0.797 0.021 0.873 





















































0.090 0.845 0.113 0.790 0.030 0.948 
-
0.550 0.200 







HIPK2 Hipk2 0.317 0.359 0.141 
-
0.016 0.945 0.068 0.782 0.299 0.172 


















0.067 0.383 0.800 7.505 0.000 0.764 0.613 0.486 0.720 
IGFBP1 Igfbp1 0.377 0.089 0.878 1.118 0.042 0.318 0.581 1.199 0.022 
ILK Ilk 
-







INSR Insr 0.507 0.106 0.572 
-
0.076 0.670 0.153 0.414 0.245 0.141 




0.056 0.731 0.257 0.072 
JNK1 Mapk8 0.392 0.183 0.239 0.051 0.730 0.211 0.173 0.312 0.023 
LEPR Lepr 0.686 0.201 0.680 0.594 0.199 1.115 0.021 1.526 0.001 
MDM2 Mdm2 0.001 0.116 0.521 0.217 0.203 0.048 0.791 0.120 0.456 
MDM4 Mdm4 0.309 0.298 0.281 0.279 0.289 0.337 0.222 0.311 0.207 
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NR1I2 Nr1i2 0.805 0.306 0.204 0.498 0.030 0.782 0.001 0.783 0.000 
NR2C2 Nr2c2 0.443 0.051 0.775 
-






























p21Cip1 Cdkn1a 0.055 0.775 0.288 1.702 0.016 
-
0.253 0.736 1.225 0.066 
p300 Ep300 0.476 0.129 0.501 0.097 0.593 0.087 0.650 0.432 0.011 































PALS2 Mpp6 0.277 0.094 0.606 
-
0.002 0.991 0.192 0.289 0.221 0.169 
PCAF Kat2b 0.424 0.184 0.354 
-
0.120 0.527 0.198 0.319 0.240 0.174 
PCK1 Pck1 0.677 0.004 0.990 0.424 0.199 0.514 0.137 0.943 0.003 
PCNA Pcna 0.228 0.037 0.808 0.208 0.143 0.245 0.102 0.207 0.122 
PDK1 Pdpk1 0.279 0.092 0.564 0.054 0.723 
-
0.018 0.910 0.220 0.120 




0.129 0.450 0.106 0.551 0.236 0.136 






0.044 0.774 0.151 0.259 
PILT Tjap1 
-
0.084 0.299 0.309 0.358 0.197 
-





















0.012 0.249 0.483 0.534 0.113 0.024 0.947 
-
0.111 0.729 
PPARGC1A Ppargc1a 0.806 
-
0.172 0.624 0.249 0.452 0.623 0.071 1.064 0.001 
PTEN Pten 0.131 0.001 0.995 
-












PXN Pxn 0.248 
-
0.126 0.367 0.059 0.652 
-





















RORA Rora 0.240 0.063 0.759 
-
0.141 0.470 0.063 0.758 
-
0.054 0.768 












SCO2 Sco2 0.082 - 0.714 0.026 0.942 0.427 0.251 0.310 0.354 
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0.142 
SEPP1 Sepp1 0.386 0.167 0.376 0.116 0.521 0.284 0.133 0.247 0.141 
SIRT Sirt1 0.214 0.016 0.938 0.066 0.732 
-
0.119 0.560 0.299 0.092 
Slug Snai2 0.429 
-










STAG1 Stag1 0.180 0.023 0.880 
-
0.157 0.274 0.048 0.750 0.153 0.247 
STAT3 Stat3 0.227 
-
0.364 0.151 0.348 0.142 0.043 0.862 0.271 0.223 
Survivin Birc5 
-
0.039 0.321 0.580 1.432 0.008 
-
0.403 0.507 0.053 0.920 
SYMPK Sympk 0.080 
-
0.071 0.652 0.061 0.681 
-
0.018 0.910 0.115 0.408 
Teap Trp53inp1 0.171 0.270 0.336 0.427 0.110 0.359 0.200 0.659 0.009 
TGF-β Tgfb3 
-





TGFBR3  Tgfbr3 0.436 0.114 0.564 
-
0.108 0.570 0.104 0.600 0.170 0.332 










TOPBP1 Topbp1 0.303 
-
0.238 0.201 0.137 0.424 0.097 0.592 0.133 0.406 
TRAP220 Med1 0.350 0.083 0.572 0.036 0.798 
-






































































10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol r logFC p logFC p logFC p logFC p 
APAF1 Apaf1 0.020 0.141 0.693 0.775 0.018 0.373 0.290 0.037 0.908 
APC Apc 0.413 0.334 0.112 0.247 0.219 0.332 0.115 0.452 0.016 
ASK1 Map3k5 0.525 0.195 0.382 0.019 0.928 0.152 0.494 0.294 0.137 
ATM Atm 0.005 0.105 0.576 -0.050 0.780 0.011 0.954 -0.078 0.646 
ATR Atr 0.422 0.237 0.206 0.302 0.089 0.340 0.068 0.422 0.011 
AXIN Axin1 0.117 -0.146 0.373 -0.029 0.851 -0.154 0.349 0.088 0.540 
B-RAF Braf 0.417 -0.058 0.768 -0.284 0.132 0.114 0.560 0.303 0.080 
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BAD Bad 0.476 -0.024 0.925 0.089 0.711 0.240 0.339 0.415 0.062 
BAK Bak1 -0.276 0.001 0.996 0.172 0.541 -0.274 0.363 -0.446 0.093 
BAX Bax -0.138 -0.095 0.696 0.118 0.604 -0.205 0.403 -0.219 0.312 
BCL2 Bcl2 -0.221 0.665 0.077 0.396 0.274 -0.449 0.265 -0.401 0.256 
BclXL Bcl2l1 -0.005 0.134 0.473 0.224 0.205 -0.077 0.684 0.065 0.695 
BIM Bcl2l11 0.546 0.078 0.774 0.328 0.199 0.371 0.167 0.574 0.016 
BMPR2 Bmpr2 0.334 0.618 0.038 0.610 0.032 0.562 0.060 0.606 0.024 
BRCA1 Brca1 0.463 0.008 0.985 0.734 0.055 0.903 0.024 1.072 0.003 
c-Fos Fos 0.121 -1.152 0.104 0.271 0.656 -0.193 0.770 0.217 0.705 
c-Jun Jun -0.025 -0.027 0.943 0.834 0.017 -0.052 0.891 -0.014 0.966 
c-RAF Raf1 -0.299 -0.165 0.253 -0.215 0.116 -0.278 0.055 -0.247 0.052 
C3G Rapgef1 0.321 0.178 0.169 0.258 0.036 0.109 0.400 0.215 0.062 
Caspase9 Casp9 -0.257 -0.279 0.109 -0.157 0.336 -0.164 0.344 -0.471 0.002 
CBL Cbl 0.217 -0.226 0.512 0.034 0.916 0.044 0.897 0.089 0.766 
CBP Crebbp 0.395 0.196 0.375 0.185 0.379 0.138 0.533 0.399 0.042 
CCND1 Ccnd1 0.103 0.588 0.224 1.520 0.001 1.324 0.006 0.226 0.601 
CDHE Cdh1 -0.251 0.025 0.945 0.151 0.656 -0.722 0.048 -0.405 0.200 
CDK2 Cdk2 0.027 0.145 0.420 -0.176 0.315 0.068 0.709 -0.078 0.631 
CHK2 Chek2 -0.238 0.188 0.623 0.426 0.234 0.330 0.386 -0.226 0.524 
CRK Crk 0.303 0.242 0.138 0.011 0.943 0.190 0.245 0.274 0.060 
CTNNβ Ctnnb1 -0.363 -0.100 0.550 -0.083 0.601 -0.220 0.190 -0.268 0.069 
CTNNδ Ctnnd1 -0.070 -0.185 0.187 -0.089 0.502 -0.154 0.274 -0.124 0.314 
DAXX Daxx -0.147 -0.233 0.212 -0.204 0.247 -0.389 0.040 -0.237 0.152 
DNAPK  Prkdc -0.237 -0.157 0.479 -0.085 0.682 -0.346 0.126 -0.229 0.246 
DSH Dvl1 0.490 -0.054 0.744 0.094 0.547 0.168 0.306 0.288 0.047 
ELK-1 Elk1 -0.377 -0.063 0.808 0.045 0.852 -0.388 0.142 -0.412 0.077 
EPAC1 Rapgef3 -0.192 0.200 0.525 0.094 0.754 -0.223 0.498 -0.083 0.774 
FADD Fadd -0.480 -0.293 0.095 -0.301 0.070 -0.415 0.019 -0.565 0.000 
FAK Ptk2 -0.093 0.133 0.357 0.032 0.819 -0.038 0.797 0.021 0.873 
FAS Fas 0.107 0.015 0.932 0.319 0.043 0.096 0.570 0.187 0.212 
FLIP Cflar 0.329 0.243 0.163 0.046 0.782 0.211 0.225 0.278 0.072 
FOXO1 Foxo1 0.603 0.236 0.302 0.322 0.139 0.382 0.094 0.681 0.001 
FYN Fyn -0.297 0.002 0.993 0.118 0.519 0.012 0.953 -0.240 0.171 
GRB2 Grb2 -0.346 -0.098 0.434 0.003 0.982 -0.104 0.405 -0.123 0.266 
GSK3β Gsk3b 0.117 0.144 0.273 0.063 0.614 0.006 0.966 0.095 0.416 
HAT1 Hat1 -0.099 0.082 0.702 0.107 0.596 0.106 0.620 -0.017 0.929 
HIF1α Hif1a 0.060 0.008 0.954 -0.089 0.502 -0.113 0.421 -0.054 0.661 
HIPK2 Hipk2 0.317 0.359 0.141 -0.016 0.945 0.068 0.782 0.299 0.172 
IRS1 Irs1 0.120 -0.229 0.408 -0.191 0.466 -0.129 0.639 0.412 0.089 
MAX Max -0.149 0.166 0.250 0.098 0.476 -0.038 0.795 -0.022 0.866 
MDM2 Mdm2 0.001 0.116 0.521 0.217 0.203 0.048 0.791 0.120 0.456 
MIZ1 Zbtb17 -0.167 -0.035 0.846 -0.020 0.907 -0.122 0.500 -0.181 0.262 
MYC Myc -0.042 0.872 0.151 0.459 0.431 0.226 0.713 -0.618 0.261 
NBS1 Nbn 0.141 0.014 0.925 -0.089 0.534 -0.079 0.604 0.024 0.857 
NCSTN Ncstn 0.043 -0.233 0.123 0.029 0.840 -0.005 0.972 -0.009 0.944 
NF1 Nf1 0.031 0.026 0.875 -0.134 0.388 -0.085 0.603 0.005 0.972 
NICD Notch1 0.150 -0.173 0.398 0.081 0.675 0.095 0.640 0.226 0.207 
NLK Nlk -0.352 0.120 0.533 -0.227 0.224 -0.041 0.834 -0.212 0.226 
p18INK4C Cdkn2c 0.118 0.474 0.161 0.528 0.101 0.653 0.052 0.545 0.073 
p21CIP1 Cdkn1a 0.055 0.775 0.288 1.702 0.016 -0.253 0.736 1.225 0.066 
p27KIP1 Cdkn1b -0.152 0.054 0.745 -0.047 0.766 -0.197 0.243 -0.047 0.748 
p300 Ep300 0.476 0.129 0.501 0.097 0.593 0.087 0.650 0.432 0.011 
p53 Trp53 -0.159 0.136 0.551 0.326 0.131 -0.272 0.245 -0.076 0.711 
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PTCH Ptch1 0.204 -0.103 0.684 -0.136 0.572 -0.397 0.125 0.184 0.410 
PUMA Bbc3 -0.311 -0.894 0.013 -0.599 0.071 -0.364 0.293 -0.659 0.033 
RalGAP Ralbp1 -0.357 0.061 0.689 0.004 0.980 -0.136 0.373 -0.318 0.019 
RALGEF Ralgds -0.171 0.225 0.595 0.514 0.198 0.222 0.602 -0.368 0.345 
RASGAP Rasa1 0.001 0.057 0.695 -0.090 0.516 -0.034 0.818 -0.048 0.710 
RASGRP Rasgrp1 -0.187 -0.031 0.932 0.175 0.608 0.029 0.936 -0.592 0.077 
Rb Rb1 -0.315 0.052 0.757 -0.338 0.039 -0.251 0.146 -0.217 0.153 
RBL1 Rbl1 -0.021 0.645 0.161 0.934 0.032 0.086 0.858 -0.011 0.980 
RBPJK Rbpj -0.100 0.052 0.722 -0.083 0.554 -0.033 0.825 -0.110 0.402 
SHC Shc1 -0.180 -0.091 0.512 0.026 0.845 -0.072 0.607 -0.258 0.036 
SHP2 Ptpn11 0.124 0.155 0.295 0.114 0.418 0.045 0.764 0.179 0.173 
SMAC Diablo -0.164 -0.006 0.968 0.107 0.482 -0.172 0.298 -0.090 0.533 
SMAD4 Smad4 0.360 0.133 0.407 -0.007 0.962 0.110 0.493 0.229 0.106 
SMAD6 Smad6 0.041 -0.118 0.627 0.074 0.744 -0.081 0.740 -0.183 0.399 
SMAD7 Smad7 0.052 0.229 0.338 0.123 0.588 0.431 0.069 -0.247 0.254 
SMO Smo -0.431 -0.320 0.397 -0.254 0.477 -0.951 0.015 -1.234 0.000 
SRC Src -0.082 0.633 0.301 1.359 0.020 -0.224 0.724 0.037 0.947 
STK6 Aurka -0.053 -0.194 0.695 0.913 0.040 -0.333 0.507 0.189 0.661 
SUFU Sufu 0.011 -0.010 0.978 0.343 0.298 0.214 0.547 0.094 0.768 
TAB1 Tab2 0.270 -0.086 0.639 -0.147 0.397 -0.244 0.183 0.322 0.046 
tBID Bid -0.364 -0.040 0.835 -0.201 0.275 -0.184 0.345 -0.408 0.019 
TGFβR1 Tgfbr1 0.221 0.328 0.077 0.288 0.103 0.280 0.132 0.358 0.031 
TGFβR2 Tgfbr2 0.066 0.076 0.665 0.151 0.363 0.055 0.755 0.032 0.835 





10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol  r logFC p logFC p logFC p logFC p 
ATG10 Atg10 -0.125 0.083 0.725 -0.177 0.441 0.043 0.856 -0.163 0.448 
ATG12 Atg12 -0.095 0.089 0.566 0.096 0.513 -0.052 0.738 -0.007 0.960 
ATG13 Atg13 -0.003 -0.132 0.372 -0.241 0.088 -0.143 0.335 -0.097 0.458 
ATG16L1 Atg16l1 0.651 0.036 0.842 0.033 0.848 0.144 0.427 0.466 0.004 
ATG3 Atg3 0.411 0.006 0.972 -0.094 0.553 0.188 0.256 0.160 0.278 
ATG5 Atg5 0.319 0.052 0.731 0.087 0.546 0.167 0.269 0.163 0.226 
ATG7 Atg7 -0.403 -0.189 0.229 -0.108 0.465 -0.277 0.080 -0.358 0.010 
BCL2 Bcl2 -0.221 0.665 0.077 0.396 0.274 -0.449 0.265 -0.401 0.256 
BECN1 Becn1 -0.366 0.115 0.361 -0.052 0.665 -0.123 0.333 -0.024 0.831 
FIP200 Rb1cc1 0.399 0.184 0.299 0.049 0.773 0.171 0.335 0.273 0.083 
LAMP1 Lamp1 -0.301 -0.006 0.973 0.007 0.963 -0.116 0.472 -0.100 0.478 
LAMP2 Lamp2 -0.611 -0.130 0.494 -0.260 0.152 -0.272 0.155 -0.192 0.253 
LC3-II Map1lc3a 0.450 -0.003 0.986 0.106 0.572 0.183 0.353 0.497 0.004 
LC3-II Map1lc3b 0.486 -0.009 0.956 0.133 0.369 0.109 0.485 0.238 0.085 
mTOR Mtor -0.119 0.060 0.704 0.159 0.289 0.043 0.787 -0.122 0.384 
NBR1 Nbr1 0.080 -0.032 0.843 -0.176 0.249 -0.051 0.752 -0.015 0.915 
SQSTM1 Sqstm1 -0.287 0.000 0.999 0.200 0.481 -0.483 0.110 -0.475 0.072 
STX17 Stx17 0.403 0.117 0.464 -0.034 0.824 0.199 0.210 0.160 0.257 
ULK1 Ulk1 -0.040 -0.384 0.029 -0.214 0.197 -0.290 0.098 -0.103 0.504 
WDFY3 Wdfy3 0.471 0.120 0.531 0.106 0.561 0.198 0.302 0.309 0.070 
WIPI1 Wipi1 0.054 -0.500 0.019 -0.287 0.148 -0.371 0.079 -0.174 0.344 



















0 0.523 -0.002 0.991 -0.016 0.930 0.165 0.382 0.322 0.055 
ACAA1 Acaa1a 0.364 0.098 0.609 0.178 0.323 0.286 0.129 0.158 0.346 
Acaa1b Acaa1b 0.340 0.334 0.329 0.184 0.574 0.655 0.055 0.551 0.072 
ACAA2 Acaa2 0.309 0.054 0.780 -0.024 0.896 0.132 0.493 0.205 0.230 
ACADM Acadm 0.561 0.138 0.510 0.243 0.222 0.384 0.065 0.601 0.001 
ACO1 Aco1 0.057 -0.037 0.829 -0.085 0.606 -0.056 0.746 -0.013 0.932 
ACO2 Aco2 0.698 0.123 0.600 0.349 0.117 0.513 0.028 0.652 0.002 
ACSL1 Acsl1 0.247 0.390 0.179 -0.073 0.794 0.234 0.422 0.143 0.581 
ACSL3 Acsl3 0.024 -0.361 0.132 -0.082 0.715 0.088 0.711 -0.402 0.056 
ACSL4 Acsl4 -0.161 0.140 0.550 0.298 0.179 0.062 0.792 -0.162 0.434 
ACSL5 Acsl5 -0.021 -0.622 0.011 -0.484 0.035 -0.320 0.185 -0.242 0.254 
ADRB3 Adrb3 -0.524 -0.341 0.498 -1.337 0.007 -0.883 0.087 -1.689 0.000 
AIF Aifm1 0.086 -0.143 0.341 -0.080 0.574 -0.018 0.902 0.062 0.640 
ALDOA Aldoa 0.291 -0.060 0.753 0.237 0.191 0.093 0.625 0.226 0.181 
ALDOB Aldob 0.504 -0.169 0.509 -0.091 0.705 0.174 0.494 0.452 0.046 
ALDOC Aldoc 0.152 -0.490 0.215 0.132 0.721 0.167 0.665 -0.176 0.608 
APP App -0.016 0.306 0.340 0.670 0.028 0.244 0.448 0.269 0.347 
ATP5A1 Atp5a1 0.575 -0.066 0.715 -0.075 0.660 0.141 0.431 0.222 0.163 
ATP5B Atp5b 0.608 0.007 0.968 0.061 0.725 0.211 0.244 0.352 0.029 
ATP5C1 Atp5c1 0.683 0.085 0.650 0.090 0.615 0.302 0.106 0.362 0.030 
ATP5D Atp5d 0.348 -0.031 0.846 0.056 0.708 0.065 0.679 0.176 0.205 
ATP5F1 Atp5f1 0.662 0.036 0.831 0.033 0.838 0.280 0.099 0.316 0.037 
ATP5G3 Atp5g3 0.520 0.163 0.313 0.005 0.972 0.301 0.061 0.313 0.029 
ATP5H Atp5h 0.687 -0.067 0.717 -0.014 0.937 0.266 0.149 0.381 0.020 
ATP5J Atp5j 0.267 0.038 0.814 -0.120 0.436 0.138 0.393 0.099 0.489 
ATP5J2 Atp5j2 0.360 0.175 0.317 -0.007 0.966 0.267 0.125 0.255 0.100 
AUH Auh 0.032 0.079 0.611 -0.119 0.422 0.004 0.978 0.001 0.995 
BCL2 Bcl2 -0.221 0.665 0.077 0.396 0.274 -0.449 0.265 -0.401 0.256 
BECN1 Becn1 -0.366 0.115 0.361 -0.052 0.665 -0.123 0.333 -0.024 0.831 
BPGM Bpgm -0.142 -0.084 0.666 0.123 0.500 -0.226 0.251 0.207 0.226 
CAMK4 Camk4 0.023 0.409 0.340 0.055 0.896 -0.389 0.397 0.076 0.845 
Caspase 3 Casp3 -0.315 -0.439 0.038 -0.312 0.115 -0.059 0.774 -0.472 0.011 
Caspase 8 Casp8 0.075 0.093 0.508 0.039 0.770 0.047 0.737 -0.072 0.568 
Caspase 9 Casp9 -0.257 -0.279 0.109 -0.157 0.336 -0.164 0.344 -0.471 0.002 
CAT Cat -0.805 -0.091 0.700 -0.470 0.039 -0.487 0.043 -0.668 0.001 
CHUK Chuk 0.065 0.152 0.458 -0.183 0.349 0.035 0.865 -0.021 0.908 
COX4I1 Cox4i1 0.429 -0.070 0.693 0.002 0.993 0.155 0.381 0.202 0.199 
COX5A Cox5a 0.576 -0.010 0.952 -0.054 0.740 0.230 0.176 0.293 0.053 
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COX6A1 Cox6a1 0.406 0.082 0.596 -0.055 0.706 0.049 0.752 0.205 0.135 
COX6B1 Cox6b1 0.367 0.100 0.548 -0.003 0.987 0.158 0.344 0.229 0.122 
COX7A1 Cox7a1 0.820 0.405 0.386 0.721 0.099 1.188 0.008 1.585 0.000 
COX7A2 Cox7a2 -0.035 0.050 0.751 -0.173 0.300 -0.024 0.893 -0.017 0.911 
COX7B Cox7b 0.545 0.179 0.410 -0.066 0.752 0.400 0.065 0.404 0.037 
COX8A Cox8a 0.627 0.119 0.465 -0.027 0.863 0.247 0.130 0.298 0.040 
CRTC3 Crtc3 -0.027 -0.254 0.137 -0.181 0.258 -0.286 0.096 -0.041 0.780 
CS Cs -0.012 -0.604 0.005 -0.502 0.014 -0.238 0.266 -0.259 0.170 
DHOH Dhodh -0.254 -0.337 0.151 0.007 0.972 -0.111 0.627 -0.262 0.204 
DHTKD1 Dhtkd1 0.515 0.213 0.316 0.040 0.842 0.355 0.094 0.333 0.078 
DJ - 1 Park7 0.310 0.002 0.986 -0.045 0.741 0.115 0.416 0.181 0.149 
DLD Dld 0.453 0.035 0.817 -0.081 0.570 0.093 0.534 0.243 0.067 
DLST Dlst 0.479 0.107 0.519 0.124 0.433 0.242 0.144 0.311 0.035 
ECHS1 Echs1 0.632 -0.040 0.833 -0.011 0.950 0.319 0.092 0.289 0.086 
ECI1 Eci1 0.315 0.098 0.596 0.029 0.870 0.364 0.048 0.136 0.408 
ECI2 Eci2 0.519 0.378 0.164 0.191 0.461 0.501 0.065 0.425 0.080 
EHHADH Ehhadh 0.721 0.463 0.318 1.047 0.019 1.570 0.001 1.803 0.000 
ENO1 Eno1 0.524 -0.496 0.113 -0.147 0.615 0.086 0.778 0.433 0.108 
ENO3 Eno3 0.077 0.256 0.361 -0.183 0.507 -0.074 0.798 -0.012 0.962 
FBP1 Fbp1 0.117 -0.036 0.851 -0.076 0.681 0.079 0.682 0.065 0.702 
FH Fh1 0.161 -0.215 0.233 -0.012 0.946 -0.067 0.709 0.071 0.653 
FIS1 Fis1 0.128 -0.052 0.752 0.094 0.545 0.045 0.784 0.071 0.624 
FURIN Furin 0.598 -0.163 0.353 -0.128 0.441 -0.020 0.908 0.205 0.186 
GAPDH Gapdh 0.360 -0.139 0.484 -0.112 0.552 -0.076 0.701 0.262 0.134 
GNAS Gnas -0.311 0.014 0.928 -0.036 0.811 -0.116 0.459 -0.069 0.620 
GPD2 Gpd2 0.235 -0.267 0.329 -0.510 0.050 -0.056 0.837 0.147 0.541 
GPI Gpi1 0.571 -0.176 0.505 0.023 0.926 0.187 0.474 0.625 0.007 
GPX4 Gpx4 0.057 0.208 0.384 0.575 0.011 0.274 0.251 0.284 0.182 
GPX7 Gpx7 0.074 0.809 0.208 1.710 0.005 0.803 0.215 0.573 0.329 
GRX2  Glrx2 0.014 0.050 0.737 -0.113 0.423 0.041 0.784 0.070 0.592 
GSR Gsr -0.153 0.054 0.710 0.121 0.376 -0.187 0.198 -0.034 0.788 
HADH Hadh 0.620 0.147 0.475 0.343 0.080 0.565 0.006 0.511 0.005 
HADHA Hadha 0.377 0.038 0.833 0.067 0.693 0.044 0.805 0.178 0.262 
HSD17B10 
Hsd17b1
0 0.523 -0.002 0.991 -0.016 0.930 0.165 0.382 0.322 0.055 
HSD17B4 Hsd17b4 0.149 -0.001 0.997 -0.060 0.723 0.055 0.758 0.166 0.295 
HSD17B8 H2-Ke6 -0.084 -0.332 0.043 -0.167 0.281 -0.228 0.163 -0.099 0.489 
HtrA2 Htra2 0.193 -0.097 0.668 0.174 0.408 0.151 0.497 -0.007 0.970 
HTT Htt -0.338 -0.107 0.582 -0.185 0.315 -0.267 0.174 -0.313 0.070 
IDH3A Idh3a 0.806 0.181 0.412 0.233 0.266 0.541 0.013 0.850 0.000 
IDH3B Idh3b 0.631 0.148 0.324 0.073 0.611 0.256 0.088 0.300 0.024 
IDH3G Idh3g 0.371 0.054 0.668 -0.030 0.805 0.104 0.413 0.178 0.113 
IL15 Il15 0.392 0.490 0.203 0.285 0.446 0.576 0.133 0.482 0.165 
IVD Ivd 0.083 0.075 0.626 0.006 0.969 0.091 0.551 0.057 0.675 
KGDH Ogdh 0.350 -0.016 0.923 0.030 0.849 0.021 0.900 0.117 0.428 
LETM1 Letm1 -0.130 -0.091 0.533 -0.139 0.315 -0.284 0.054 0.067 0.603 
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LRRK2 Lrrk2 0.014 0.417 0.191 0.147 0.636 0.226 0.488 -0.107 0.721 
MAOA Maoa 0.678 0.006 0.974 0.224 0.203 0.559 0.002 0.559 0.001 
MAOB Maob 0.756 0.141 0.522 0.283 0.177 0.603 0.006 0.680 0.001 
MDH1 Mdh1 0.205 -0.074 0.681 -0.112 0.514 0.035 0.848 0.028 0.862 
MDH2 Mdh2 0.482 -0.093 0.652 0.258 0.185 0.204 0.320 0.518 0.005 
ME1 Me1 0.029 -0.743 0.073 -0.928 0.018 -0.228 0.577 -0.288 0.423 
ME2 Me2 -0.006 0.269 0.424 0.461 0.146 0.228 0.502 -0.076 0.803 
MIRO2 Rhot2 0.348 0.116 0.416 0.148 0.274 0.171 0.231 0.300 0.018 
MKK4 Map2k4 0.197 0.077 0.479 0.047 0.645 0.102 0.344 0.109 0.258 
mtSOD Sod2 0.568 0.162 0.327 0.034 0.827 0.255 0.122 0.320 0.029 
NCT Ncstn 0.043 -0.233 0.123 0.029 0.840 -0.005 0.972 -0.009 0.944 
NDUFA1 Ndufa11 0.343 -0.008 0.966 -0.061 0.720 0.043 0.813 0.309 0.052 
NDUFA10 Ndufa10 0.380 -0.059 0.689 -0.060 0.667 0.067 0.650 0.178 0.171 
NDUFA12 Ndufa12 0.621 0.163 0.382 -0.044 0.803 0.238 0.199 0.529 0.001 
NDUFA13 Ndufa13 -0.200 -0.008 0.956 -0.104 0.471 -0.102 0.503 -0.041 0.761 
NDUFA2 Ndufa2 0.152 0.046 0.808 -0.218 0.231 0.171 0.363 0.176 0.293 
NDUFA3 Ndufa3 0.193 0.062 0.725 -0.118 0.487 0.091 0.609 0.205 0.192 
NDUFA4 Ndufa4 0.235 0.008 0.967 -0.215 0.256 0.023 0.906 0.173 0.326 
NDUFA5 Ndufa5 0.543 0.156 0.443 -0.052 0.790 0.459 0.022 0.396 0.027 
NDUFA6 Ndufa6 0.263 0.007 0.975 -0.353 0.084 0.022 0.917 0.174 0.357 
NDUFA7 Ndufa7 0.634 0.083 0.645 0.182 0.286 0.388 0.029 0.509 0.001 
NDUFA8 Ndufa8 0.619 -0.072 0.665 0.003 0.986 0.108 0.514 0.355 0.016 
NDUFA9  Ndufa9 0.506 -0.136 0.385 -0.142 0.340 0.097 0.535 0.240 0.082 
NDUFAF1 Ndufaf1 -0.610 -0.265 0.184 -0.352 0.064 -0.390 0.053 -0.460 0.009 
NDUFB10 Ndufb10 0.543 -0.001 0.995 0.011 0.939 0.205 0.185 0.300 0.029 
NDUFB11 Ndufb11 0.296 -0.105 0.560 -0.182 0.289 0.071 0.694 0.170 0.287 
NDUFB2 Ndufb2 0.001 0.182 0.328 0.054 0.759 0.065 0.728 0.111 0.503 
NDUFB3 Ndufb3 0.139 0.030 0.867 -0.329 0.059 0.021 0.906 -0.005 0.975 
NDUFB4 Ndufb4 0.336 0.126 0.486 0.133 0.437 0.234 0.194 0.306 0.056 
NDUFB5 Ndufb5 0.524 0.028 0.859 -0.107 0.474 0.202 0.194 0.242 0.080 
NDUFB6 Ndufb6 0.463 -0.075 0.683 -0.129 0.460 0.235 0.195 0.313 0.053 
NDUFB7 Ndufb7 0.210 -0.112 0.460 -0.112 0.436 0.094 0.533 0.100 0.454 
NDUFB8 Ndufb8 0.569 0.000 0.998 -0.160 0.404 0.328 0.102 0.320 0.074 
NDUFB9 Ndufb9 0.534 0.048 0.799 0.000 0.999 0.231 0.216 0.264 0.112 
NDUFS1 Ndufs1 0.478 -0.006 0.967 -0.111 0.427 0.180 0.219 0.164 0.208 
NDUFS2 Ndufs2 0.625 0.013 0.932 0.036 0.798 0.119 0.423 0.305 0.021 
NDUFS4 Ndufs4 0.355 -0.007 0.966 -0.166 0.300 0.263 0.113 0.105 0.477 
NDUFS6 Ndufs6 -0.050 0.121 0.547 -0.091 0.555 0.001 0.994 0.065 0.648 
NDUFS7 Ndufs7 0.219 -0.141 0.391 -0.140 0.371 -0.018 0.914 0.065 0.652 
NDUFS8 Ndufs8 0.027 -0.019 0.899 0.063 0.651 0.065 0.654 -0.011 0.935 
NDUFV1 Ndufv1 0.572 -0.139 0.404 -0.064 0.686 0.002 0.988 0.280 0.057 
NDUFV2 Ndufv2 0.592 0.097 0.572 0.012 0.942 0.273 0.112 0.405 0.008 
NDUFV3  Ndufv3 0.374 0.102 0.491 0.025 0.858 0.089 0.548 0.223 0.088 
NOS3 Nos3 -0.093 -0.404 0.219 0.012 0.968 -0.140 0.663 -0.345 0.232 
NR1D1 Nr1d1 -0.724 -0.966 0.028 -1.327 0.002 -1.619 0.000 -1.734 0.000 
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OGDH Ogdh 0.350 -0.016 0.923 0.030 0.849 0.021 0.900 0.117 0.428 
Parkin Park2 0.012 0.161 0.636 -0.111 0.734 0.515 0.121 -0.210 0.496 
PDHA Pdha1 0.650 0.140 0.497 -0.122 0.533 0.296 0.148 0.367 0.045 
PFKL Pfkl -0.327 -0.080 0.672 0.056 0.753 -0.087 0.648 -0.128 0.448 
PFKM Pfkm 0.407 -0.325 0.099 -0.114 0.536 0.205 0.282 -0.001 0.993 
PFKP Pfkp 0.187 0.393 0.179 0.529 0.057 0.238 0.419 0.323 0.217 
PGAM1 Pgam1 0.383 0.018 0.911 0.009 0.953 0.039 0.803 0.328 0.018 
PGK1 Pgk1 0.756 -0.019 0.925 0.161 0.407 0.353 0.083 0.616 0.001 
PINK1 Pink1 0.640 -0.059 0.736 0.072 0.663 0.211 0.224 0.305 0.049 
PKLR Pklr -0.281 -0.556 0.146 -0.928 0.011 -0.253 0.505 -0.495 0.137 
PKM Pkm -0.155 -0.011 0.971 0.418 0.148 -0.176 0.569 -0.358 0.188 
PPARGC1A Ppargc1a 0.806 -0.172 0.624 0.249 0.452 0.623 0.071 1.064 0.001 
PPARGC1B Ppargc1b 0.189 0.051 0.824 -0.193 0.380 -0.001 0.998 -0.106 0.605 
PRX3 Prdx3 0.266 -0.107 0.511 0.132 0.391 0.166 0.306 0.171 0.234 
PRX5 Prdx5 -0.083 0.021 0.892 -0.019 0.897 -0.041 0.789 -0.007 0.962 
PSEN1 Psen1 -0.026 -0.026 0.820 0.078 0.477 -0.049 0.677 0.013 0.896 
PTEN Pten 0.131 0.001 0.995 -0.097 0.595 0.069 0.717 0.041 0.807 
SCP2 Scp2 -0.808 -0.096 0.729 -0.584 0.028 -0.608 0.031 -0.742 0.002 
SDHA Sdha 0.185 -0.084 0.658 -0.239 0.185 0.027 0.886 0.013 0.937 
SDHB Sdhb 0.462 0.127 0.474 -0.026 0.876 0.195 0.271 0.193 0.220 
SDHC Sdhc 0.632 -0.009 0.957 0.101 0.502 0.244 0.121 0.251 0.073 
SDHD Sdhd 0.735 -0.042 0.850 -0.024 0.909 0.411 0.063 0.435 0.028 
SDS Sds 0.552 -0.177 0.474 0.353 0.130 0.513 0.035 0.445 0.042 
SIRT1 Sirt1 0.214 0.016 0.938 0.066 0.732 -0.119 0.560 0.299 0.092 
SLC27A1 Slc27a1 0.243 0.426 0.232 0.558 0.098 0.507 0.153 0.413 0.195 
SLC27A2 Slc27a2 -0.093 0.095 0.659 -0.196 0.340 -0.106 0.622 -0.149 0.434 
SLC27A4 Slc27a4 -0.326 -0.168 0.379 -0.070 0.699 -0.309 0.109 -0.298 0.078 
SLC27A5 Slc27a5 0.118 -0.290 0.277 -0.112 0.657 -0.093 0.727 0.005 0.982 
SUCLA2 Sucla2 0.370 0.007 0.963 -0.121 0.409 0.114 0.461 0.183 0.181 
SUCLG1 Suclg1 0.279 -0.007 0.963 0.015 0.923 0.156 0.331 0.137 0.338 
Synucleinα Snca -0.087 0.131 0.862 1.040 0.130 0.415 0.575 0.818 0.210 
TFAM Tfam 0.426 -0.001 0.992 -0.054 0.709 0.217 0.150 0.217 0.105 
TPI1 Tpi1 0.483 -0.182 0.331 0.011 0.951 0.104 0.577 0.331 0.045 
TRAK1 Trak1 0.678 0.125 0.502 0.095 0.591 0.419 0.023 0.301 0.068 
TRX2 Txn2 0.583 0.027 0.862 0.236 0.109 0.181 0.242 0.340 0.014 
TRXR2 Txnrd2 0.093 -0.187 0.271 -0.124 0.437 -0.015 0.931 0.033 0.825 
UCP2 Ucp2 -0.133 0.204 0.479 0.582 0.033 0.177 0.540 -0.190 0.458 
UQCR10 Uqcr10 0.369 0.246 0.170 0.020 0.907 0.319 0.074 0.419 0.008 
UQCRB Uqcrb 0.516 0.178 0.401 -0.102 0.618 0.259 0.226 0.308 0.106 
UQCRC1 Uqcrc1 0.507 -0.064 0.712 -0.068 0.684 0.090 0.606 0.228 0.140 
UQCRC2 Uqcrc2 0.688 0.012 0.944 -0.043 0.795 0.194 0.263 0.331 0.032 
UQCRFS1 Uqcrfs1 0.618 0.012 0.942 -0.067 0.660 0.212 0.181 0.320 0.023 
Xanthine 
oxidase Xdh 0.107 0.077 0.634 0.158 0.303 -0.013 0.937 0.036 0.799 
 




10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol r logFC p logFC p logFC p logFC p 
CBS/CBSL Cbs -0.549 -0.626 0.021 -0.500 0.050 -0.701 0.010 -0.565 0.016 
CRY1 Cry1 0.785 0.676 0.138 1.026 0.018 1.333 0.003 1.800 0.000 
CRY2 Cry2 0.441 0.071 0.687 0.056 0.741 0.189 0.284 0.159 0.308 
CTH Cth 0.550 0.268 0.302 0.461 0.063 0.550 0.034 1.054 0.000 
PER1 Per1 0.849 0.284 0.455 0.544 0.132 0.868 0.021 1.301 0.000 
PER2 Per2 0.724 0.671 0.039 0.828 0.008 1.028 0.002 0.950 0.001 
SIRT1 Sirt1 0.214 0.016 0.938 0.066 0.732 -0.119 0.560 0.299 0.092 






  10CR 20CR 30CR 40CR 
Symbol 
Gene 
Symbol r logFC p logFC p logFC p logFC p 
ABCA1 Abca1 -0.518 -0.087 0.602 -0.172 0.280 -0.230 0.169 -0.264 0.073 
ABCG1 Abcg1 -0.038 0.130 0.615 0.320 0.190 0.041 0.873 -0.302 0.192 
ABCG5 Abcg5 0.286 0.287 0.179 0.106 0.604 0.276 0.196 0.139 0.464 
ABCG8 Abcg8 -0.078 -0.054 0.805 -0.279 0.179 -0.140 0.522 -0.319 0.097 
AE2 Slc4a2 0.109 0.029 0.861 0.205 0.185 -0.107 0.518 0.010 0.945 
AHR Ahr 0.468 -0.012 0.957 0.117 0.564 0.293 0.166 0.422 0.025 
ALAS1 Alas1 0.595 0.988 0.033 1.105 0.013 1.421 0.002 0.913 0.030 
ALDH1A1 Aldh1a1 -0.379 0.234 0.324 -0.117 0.606 -0.105 0.660 -0.037 0.860 
ALDH1A7 Aldh1a7 -0.034 0.029 0.894 0.172 0.401 0.144 0.504 -0.002 0.991 
ALDH3A2 Aldh3a2 0.595 0.450 0.133 0.489 0.088 0.771 0.010 0.882 0.001 
ANKRA2 Ankra2 -0.150 0.140 0.518 -0.085 0.685 0.060 0.782 -0.153 0.436 
ApoA1 Apoa1 -0.468 -0.682 0.033 -0.354 0.239 -0.588 0.066 -0.797 0.004 
ApoB Apob -0.239 0.044 0.827 -0.174 0.358 -0.202 0.313 -0.057 0.747 
APOC2 Apoc2 0.073 0.211 0.366 0.551 0.013 0.171 0.464 0.218 0.293 
APOE Apoe -0.364 -0.248 0.238 -0.216 0.277 -0.331 0.116 -0.233 0.207 
ARNT Arnt 0.457 0.085 0.566 0.091 0.519 0.273 0.063 0.201 0.126 
ASBT Slc10a2 -0.623 -0.542 0.345 -0.396 0.463 -1.162 0.049 -1.764 0.001 
BAAT Baat -0.151 0.050 0.809 -0.180 0.358 -0.015 0.943 0.163 0.372 
BACS Slc27a5 0.118 -0.290 0.277 -0.112 0.657 -0.093 0.727 0.005 0.982 
BSEP Abcb11 -0.627 -0.395 0.138 -0.610 0.016 -0.552 0.039 -0.446 0.055 
CAR Nr1i3 0.691 0.674 0.140 0.656 0.133 1.327 0.004 1.153 0.005 
CAT Cat -0.805 -0.091 0.700 -0.470 0.039 -0.487 0.043 -0.668 0.001 
CCRP Dnajc7 0.217 -0.023 0.850 -0.153 0.183 -0.004 0.971 0.020 0.853 
CD14 Cd14 -0.154 0.506 0.365 0.982 0.064 -0.159 0.782 -0.274 0.589 
CES3 Ces3a -0.924 -0.247 0.769 -1.607 0.051 -2.929 0.002 -4.669 0.000 
ChREBP Mlxipl -0.493 -0.236 0.412 -0.743 0.007 -0.638 0.028 -0.520 0.040 
c-Jun Jun -0.025 -0.027 0.943 0.834 0.017 -0.052 0.891 -0.014 0.966 
CPT1A Cpt1a 0.390 0.173 0.452 0.285 0.193 0.300 0.191 0.191 0.352 
c-RAF Raf1 -0.299 -0.165 0.253 -0.215 0.116 -0.278 0.055 -0.247 0.052 
CRM-1 Xpo1 -0.081 -0.079 0.647 -0.266 0.104 -0.171 0.323 -0.136 0.372 
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CUL3 Cul3 0.353 0.026 0.864 -0.092 0.531 -0.025 0.870 0.187 0.169 
CYP1A2 Cyp1a2 -0.687 -0.123 0.821 -0.924 0.078 -1.176 0.036 -2.285 0.000 
CYP1B1 Cyp1b1 -0.231 0.206 0.729 -0.544 0.347 -0.757 0.223 -1.001 0.067 
CYP27A1 Cyp27a1 -0.004 -0.562 0.060 -0.470 0.095 -0.280 0.345 -0.157 0.546 
CYP2A6 Cyp2a5 0.169 1.206 0.015 1.435 0.003 1.390 0.005 1.171 0.009 
CYP2B6 Cyp2b10 -0.133 1.602 0.277 4.118 0.008 1.852 0.213 3.296 0.024 
CYP2C8 Cyp2c39 0.876 0.691 0.457 2.302 0.011 3.947 0.000 4.260 0.000 
CYP3A5 Cyp3a11 0.415 0.541 0.169 1.047 0.005 0.772 0.049 1.286 0.000 
CYP3A7 Cyp3a13 0.611 0.099 0.736 0.829 0.003 0.649 0.025 1.007 0.000 
CYP4A14 Cyp4a14 0.822 2.801 0.015 4.426 0.000 5.538 0.000 6.391 0.000 
CYP4A22 Cyp4a10 0.830 1.612 0.047 2.220 0.005 3.406 0.000 4.024 0.000 
CYP7A1 Cyp7a1 0.394 0.316 0.485 0.865 0.045 1.275 0.005 1.275 0.002 
CYP8B1 Cyp8b1 -0.679 -0.942 0.103 -1.523 0.006 -1.690 0.005 -2.072 0.000 
ERK5 Mapk7 -0.087 0.035 0.909 0.106 0.709 -0.127 0.682 -0.082 0.765 
FASN Fasn -0.367 -1.511 0.008 -1.297 0.014 -0.592 0.280 -1.562 0.001 
FBP1 Fbp1 0.117 -0.036 0.851 -0.076 0.681 0.079 0.682 0.065 0.702 
Fetuin B Fetub -0.149 -0.354 0.192 0.252 0.325 -0.229 0.398 -0.330 0.165 
FGFR4 Fgfr4 -0.490 -0.152 0.465 -0.059 0.765 -0.399 0.058 -0.441 0.017 
FOXO1 Foxo1 0.603 0.236 0.302 0.322 0.139 0.382 0.094 0.681 0.001 
FOXO2 Foxo3 0.168 -0.019 0.924 -0.241 0.220 -0.120 0.562 0.015 0.933 
FTL Ftl1 0.220 0.118 0.549 0.193 0.301 0.164 0.402 0.214 0.220 
FXR Nr1h4 0.190 0.053 0.792 -0.168 0.379 0.148 0.460 0.106 0.548 
G6PC G6pc 0.183 -0.646 0.195 -0.285 0.543 0.167 0.733 0.657 0.133 
GCLC Gclc -0.388 0.246 0.368 0.017 0.948 -0.571 0.041 -0.504 0.038 
GR Nr3c1 0.055 0.191 0.265 -0.069 0.671 0.075 0.664 -0.030 0.845 
GSTM1 Gstm2 0.284 0.024 0.914 0.454 0.031 0.354 0.109 -0.020 0.917 
GSTM2 Gstm7 -0.344 -0.306 0.099 -0.338 0.054 -0.342 0.065 -0.385 0.018 
HDAC4 Hdac4 0.193 -0.153 0.629 0.013 0.966 0.018 0.953 0.128 0.642 
HDAC5 Hdac5 -0.265 -0.543 0.005 -0.505 0.006 -0.435 0.025 -0.343 0.043 
HL Lipc -0.575 -0.320 0.323 -0.763 0.014 -0.649 0.047 -0.784 0.006 
HMGCS2 Hmgcs2 0.412 0.102 0.677 -0.066 0.779 0.183 0.455 0.356 0.102 
HNF1α Hnf1a 0.203 -0.285 0.066 -0.149 0.306 -0.277 0.074 0.115 0.392 
HNF4α Hnf4a 0.338 -0.104 0.665 0.075 0.744 -0.060 0.802 0.316 0.139 
HO-1 Hmox1 0.117 -0.006 0.985 0.739 0.020 -0.080 0.813 0.241 0.418 
IGFBP1 Igfbp1 0.377 0.089 0.878 1.118 0.042 0.318 0.581 1.199 0.022 
IL-1 Il1b -0.231 -1.102 0.055 -0.394 0.447 -1.195 0.040 -0.497 0.304 
INSR Insr 0.507 0.106 0.572 -0.076 0.670 0.153 0.414 0.245 0.141 
IRAK Irak1 -0.245 0.026 0.842 0.080 0.521 -0.091 0.486 -0.013 0.908 
KEAP1 Keap1 0.076 0.009 0.946 -0.022 0.857 0.008 0.950 0.084 0.452 
LBP Lbp 0.527 -0.388 0.206 0.429 0.136 0.184 0.543 0.919 0.001 
LPL Lpl -0.185 0.763 0.208 0.938 0.107 -0.668 0.285 -0.623 0.250 
LRH-1 Nr5a2 0.161 -0.111 0.515 -0.169 0.297 -0.105 0.537 0.106 0.481 
MAF Maf 0.259 0.052 0.748 0.210 0.175 0.236 0.146 0.176 0.223 
MD-2 Ly96 -0.313 -0.231 0.436 -0.253 0.368 -0.798 0.011 -0.412 0.122 
MDR1 Abcb1a 0.576 1.621 0.014 2.488 0.000 2.378 0.000 2.826 0.000 
MDR3 Abcb4 0.260 0.286 0.150 0.303 0.110 0.114 0.568 0.310 0.080 
MEK5 Map2k5 0.099 -0.098 0.545 0.004 0.978 -0.200 0.220 -0.058 0.687 
MEKK1 Map3k1 -0.017 0.233 0.317 0.167 0.452 -0.016 0.946 0.145 0.486 
MGMT Mgmt 0.011 0.128 0.611 0.040 0.868 0.215 0.390 -0.103 0.651 
MRP2 Abcc2 0.241 0.209 0.333 0.190 0.355 0.132 0.543 0.139 0.470 
MRP3 Abcc3 0.083 0.231 0.420 0.632 0.020 0.669 0.019 0.092 0.718 
MRP4 Abcc4 0.073 1.657 0.007 2.157 0.000 0.988 0.108 1.217 0.030 
MTTP Mttp 0.098 -0.256 0.280 -0.348 0.121 -0.111 0.638 0.052 0.801 
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MYD88 Myd88 0.040 -0.245 0.162 -0.095 0.564 -0.174 0.318 0.009 0.954 
NFκBp65 Rela -0.300 -0.150 0.371 -0.134 0.396 -0.409 0.016 -0.292 0.049 
NR0B2 Nr0b2 -0.288 -0.450 0.261 -0.159 0.673 -0.627 0.120 -0.554 0.114 
NRF2 Nfe2l2 -0.139 -0.035 0.828 -0.105 0.491 -0.146 0.365 -0.057 0.687 
NTCP Slc10a1 0.248 -0.190 0.627 -0.560 0.135 -0.021 0.958 -0.033 0.924 
OATP4 Slco1b2 -0.407 0.083 0.834 -0.513 0.178 -0.394 0.326 -0.677 0.054 
OSTB Slc51b 0.578 0.160 0.838 1.659 0.023 1.641 0.031 2.322 0.001 
PAPSS2 Papss2 0.585 0.133 0.603 0.265 0.276 0.622 0.014 0.321 0.157 
PEPCK Pck2 0.047 0.229 0.534 0.905 0.008 0.269 0.464 0.047 0.886 
PERK Eif2ak3 -0.206 0.109 0.663 -0.187 0.438 -0.587 0.024 -0.329 0.145 
PGC-1α Ppargc1a 0.806 -0.172 0.624 0.249 0.452 0.623 0.071 1.064 0.001 
PGC-1β Ppargc1b 0.189 0.051 0.824 -0.193 0.380 -0.001 0.998 -0.106 0.605 
PKLR Pklr -0.281 -0.556 0.146 -0.928 0.011 -0.253 0.505 -0.495 0.137 
PLTP Pltp -0.122 -0.973 0.005 -0.269 0.404 -0.156 0.647 -0.992 0.001 
PON1 Pon1 0.017 -0.150 0.613 -0.284 0.315 -0.070 0.813 -0.008 0.974 
PPAR Ppara 0.257 -0.004 0.987 -0.055 0.811 0.114 0.637 -0.037 0.864 
PPARγ Pparg -0.012 0.249 0.483 0.534 0.113 0.024 0.947 -0.111 0.729 
PXR Nr1i2 0.805 0.306 0.204 0.498 0.030 0.782 0.001 0.783 0.000 
RARα Rara -0.358 0.048 0.765 0.051 0.739 -0.203 0.217 -0.363 0.013 
RXRα Rxra 0.348 -0.026 0.890 -0.001 0.996 0.041 0.828 0.135 0.420 
SCD1 Scd1 -0.123 -0.561 0.125 -0.670 0.053 -0.278 0.444 -0.438 0.169 
SDC1 Sdc1 0.257 -0.136 0.497 0.441 0.020 0.208 0.297 0.375 0.035 
SITPEC Ecsit 0.136 0.053 0.751 -0.119 0.457 -0.069 0.683 0.111 0.451 
SMRT Ncor2 -0.095 -0.029 0.872 0.219 0.197 -0.123 0.495 -0.074 0.643 
SOD3 Sod3 -0.247 -0.172 0.466 0.149 0.501 -0.314 0.186 -0.498 0.017 
SR-BI Scarb1 0.155 -0.154 0.397 0.015 0.930 -0.146 0.422 0.125 0.438 
SRC-1 Ncoa1 0.269 -0.018 0.903 -0.090 0.507 0.104 0.465 0.194 0.123 
SREBP1 Srebf1 -0.463 -0.260 0.435 -0.102 0.745 -0.343 0.304 -0.914 0.002 
SULT2A1 Sult2a3 0.570 0.000 1.000 0.000 1.000 4.322 0.017 6.585 0.001 
SUMO1 Sumo1 0.202 0.335 0.047 0.142 0.380 0.341 0.044 0.180 0.235 
TEBP Ptges3 -0.223 0.113 0.432 0.002 0.991 0.056 0.700 -0.021 0.869 
TLR4 Tlr4 -0.006 -0.007 0.979 0.146 0.576 0.044 0.875 0.005 0.986 
TRAF2 Traf2 -0.004 0.326 0.163 0.400 0.071 0.112 0.638 0.206 0.330 
TRAF6 Traf6 0.420 0.135 0.414 0.082 0.601 0.150 0.365 0.383 0.009 
UGT1A1 Ugt1a1 0.670 -0.010 0.972 0.310 0.249 0.523 0.063 0.805 0.001 
UGT1A9 Ugt1a9 0.427 0.722 0.114 0.776 0.075 1.007 0.027 1.313 0.002 
VLDLR Vldlr 0.784 0.798 0.260 1.420 0.036 2.706 0.000 2.917 0.000 
XAP2 Aip -0.276 -0.335 0.083 0.042 0.815 -0.139 0.465 -0.453 0.008 
 
 
